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INTRODUCTION 
Infection of cattle with viruses and other intracellular pathogens causes a great 
deal of harm to the animals and poses a serious economic burden to the cattle 
industry. The most common method to combat infection has been the development 
of vaccines, but in many cases vaccines are ineffective at preventing either 
infection or disease. The goal in most vaccine production is to elicit an immune 
response that mimics protective immune responses which animal develop after 
natural infection. For many viruses, especially those which cause persistent 
infections, a cellular immune response seems to be more important for protection 
from infection than humoral immune responses. In order to artificially produce a 
cellular immune response, it is usually necessary to vaccinate an animal using 
modified live or vectored viruses. A useful tool in development of live vaccines is 
the ability to measure what segments of the viral genome elicit the cellular immune 
responses that are associated with protection in animals infected with wild-type 
virus. This can allow researchers to design modified viruses which possess only 
the parts of the genome necessary for a protective response. Unfortunately, no 
widely applicable, effective system exists for measurement of acquired cellular 
immune responses in cattle. 
The most important form of cellular immunity to viruses is generally mediated by 
class I MHC-restricted cytotoxic T lymphocytes, or CTL (5,7,40,88). An animal 
gains protective immunity when it possesses CTL which can recognize infected 
cells in the body and kill them, thereby stopping the virus life cycle. In animals such 
as mice or humans, measurements of CTL recognition are routinely performed by 
isolating CTL from the blood of an infected animal and measuring whether those 
CTL will specifically lyse infected target cells in vitro. 
2 
This method has been used to a small degree in cattle, but several technical 
obstacles prevent broad application of the technique. The greatest hurdle involves 
choice of the target cell. CTL are class I MHC-restricted, which is to say that they 
detect virus in a cell through the class I MHC antigen presentation pathway and will 
only lyse infected cells which have the same MHC genotype as they do. Because 
cattle are outbred, virtually no two animals have the same MHC genotype. So in 
order to measure CTL lysis of target cells in cattle, the CTL and the target cells must 
come from the same animal, and isolation of the target cell cannot result in the 
animal's death. Since many of the cells which are easily cultured reside in vital 
tissues, this greatly restricts the choice of a target cell. The target cell must also 
express a relatively high level of its class I MHC genes for viral antigens to be 
efficiently presented to the CTL, further limiting the choice of available cells. In 
addition, many viruses infect a limited range of cells or are difficult to culture in vitro, 
effectively eliminating all potential target cells for those viruses. Finally, many of 
the viruses which do infect cells in vitro lyse the cells they infect, creating a 
background level of lysis above which specific CTL lysis cannot be detected. 
One method that holds promise in broadening the range of potential target cells 
is retroviral gene delivery. Retroviral vectors deliver genes to cells, but once the 
genes are delivered, no new viruses are made and no virus-induced lysis occurs. 
Also, retroviral vectors are available which will infect almost any dividing bovine 
cell. By using retroviral vectors to deliver individual genes from a bovine virus to 
target cells rather than trying to infect target cells with whole virus, the hurdles of 
limited virus host cell range, difficulty in culturing virus, and virus-induced lysis are 
circumvented. An added benefit of this method is that by using a panel of retroviral 
vectors which deliver different genes from the bovine virus, it would be possible to 
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specifically determine which genes elicit a CTL lysis, the information that is so 
potentially useful to vaccine development. 
By using retroviral vectors to broaden the range of target cells available for use 
in a CTL assay, all that is then required of target cell is that they can be isolated 
without killing the animal donor, they must have a relatively high level of class I 
MHC expression, and they must be susceptible to infection with retroviral vectors. 
The first goal of this project was to choose a bovine target cell which meets these 
criteria. We then proposed to use bovine immunodeficiency virus (BIV) as a model 
virus from which to construct retroviral vectors and demonstrate expression of 
genes in target cells. 
It is our hypothesis that retroviral vectors can be used to construct bovine CTL 
target cell lines, a technique which could be used for the study of cellular immunity 
to bovine viruses and other intracellular pathogens. 
Specific Aims 
1 . Characterize and develop a bovine CTL target cell 
2. Construct a retroviral vector for delivery of target genes to bovine cells 
3. Use retroviral vectors to deliver genes to target cells and measure expression. 
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LITERATURE REVIEW 
Cellular Immunity to Viruses 
Infection by viruses and other intracellular pathogens interferes with the health 
and well-being of many animals. As long as the pathogens remain inside cells, 
they are inaccessible to soluble antibody molecules which do not penetrate host 
cell membranes. If antibodies were the only line of defense, the immune system 
would only be able to neutralize pathogens during the extracellular stages of their 
replication cycles. Therefore animals possess an additional mechanism to deal 
with intracellular infections. Nearly all host cells routinely present fragments of 
endogenously synthesized proteins on the cell surface complexed with class I 
major histocompatibility complex (MHC) molecules. In this way, the immune 
system can test for cells producing foreign proteins. Healthy cells present only 
host-derived antigens and are ignored by the immune system, but when an 
infected cell presents foreign peptide fragments on its surface, immune effector 
cells target the infected cell and lyse it (88). Cytotoxic T lymphocytes (CTL) are the 
effector cells of this immune mechanism. 
Cytotoxic T cell lysis 
CTL maturation. The precursors to co4· CD8+ T cells, or CTL, differentiate in 
the thymus. Part of the differentiation process involves rearrangement of the gene 
encoding the T cell receptor (TCR) which is used by mature CTL to detect class I 
MHC-foreign antigen complexes. This rearrangement of the TCR provides the 
cellular immune system with its ability to recognize an amazingly diverse range of 
foreign antigens. In the thymus, T cell precursors with newly rearranged TCR 
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undergo either negative or positive selection. Cells that bind MHC complexed with 
self antigens are eliminated, as are cells which do not bind any of the organism's 
class I MHC molecules. Cells that can bind the organism's class I MHC molecules 
but do not bind MHC-self antigen complexes are allowed to mature (70). Thus, 
CTL are produced which do not react to self and specifically react with foreign 
peptides bound to class I MHC. 
Once CTL are released from the thymus, they migrate throughout the body in a 
non-activated state. When a CTL initially comes into contact with a foreign antigen-
MHC complex, the CTL is stimulated to undergo cell division and activation (7). 
Division of CTL which recognize invading pathogens is important. Since the TCR 
differs between CTL, different cells will be able to recognize different antigen-MHC 
complexes. By dividing after recognizing a foreign antigen, the CTL increases the 
number of effector cells specific for infected target cells, and presumably increases 
the animal's capacity to outpace the infection. Activation of CTL is another 
important step. Activated CTL form granules containing serine esterases 
(granzymes) and perforin and upregulate expression of a ligand for the Fas 
receptor (Fasl) on their surface (40). Both of these changes prime the CTL for 
target cell killing. 
Target cell killing. When an activated CTL recognizes a foreign antigen on 
the surface of a target cell, it can kill the target cell by two different mechanisms: 
perforin secretion or Fas receptor binding (40). The major mechanism of target cell 
killing is perforin-induced lysis. Perforin is a glycoprotein which is expressed in T 
cells and natural killer (NK) cells, and when secreted, it can enter target cell 
membranes, multimerize, and form lytic pores. According to the granule exocytosis 
model of target cell killing, upon recognition of a foreign antigen, activated CTL 
release their perforin/granzyme granules onto the target cell membrane, where the 
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perforin forms pores. These pores then allow entry of water, ions, and the 
granzymes, which leads to death of the target cell. A second mechanism of target 
cell killing is Fas-mediated apoptosis. Many cell types express the Fas receptor, 
which upon crosslinking will signal the cell to undergo programmed cell death, or 
apoptosis. Activated CTL have a ligand for Fas (FasL) on their surface. When the 
TCR binds an MHC-antigen complex, the FasL molecules will bind and crosslink 
the target cell's Fas receptors, and thus begin the apoptotic cascade. For target 
cells which express Fas, the perforin-mediated and Fas-mediated killing pathway 
are used in conjunction; for cells which do not express Fas, the perforin pathway is 
used alone (40). 
Antigen processing and presentation. In order for a CTL to lyse an 
infected cell, that target cell must first present pathogen-derived antigens on the 
cell surface. When infection of a cell occurs, a series of events occurs within the 
cell leading up to the presentation of class I MHC-foreign peptide complexes on the 
cell's surface. Animal cells contain a large multicatalytic proteolytic particle called 
the proteasome which cleaves cytosolic proteins into small polypeptide fragments, 
often after ubiquitination of the original protein. A transporter in the endoplasmic 
reticulum (ER) known as TAP (transporter associated with antigen presentation) is 
involved in assembling these polypeptide fragments with the two subunits of the 
class I MHC molecule in the lumen of the ER (88). The mature class I MHC 
complex is made up of a heavy chain, a light chain, and an 8 to 12 amino acid 
antigen peptide. The antigen peptide binds in a groove in the heavy chain. In mice 
and humans this groove is the site of most of the polymorphism among different 
alleles of class I MHC (60), and it is the site of TCR binding (9). The heavy and light 
chains are cotranslationally transferred to the lumen of the ER, where they form an 
unstable complex which can be stabilized by binding either the antigen peptide 
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(25) or the lumenal side of a TAP heterodimer. When a heavy and light chain are 
bound, TAP transports cytosolic peptides, 8 to 12 amino acids long, across the 
membrane of the ER forming a mature class I MHC complex, from which TAP then 
disassociates. The mature class I MHC-antigen complex is transported from the ER 
through the Golgi apparatus to the cell surface (88). At the cell surface, the 
complex is accessible for screening by CTL, and thus the immune system. 
In vitro measurement of CTL lysis 
In the standard method used to measure CTL lysis, an animal is challenged 
with virus, and lymphocytes are isolated from the animal and co-cultured in vitro 
with virus-infected target cells which have been intracellularly labeled. Lysis of 
target cells is measured as a function of release of the intracellular label. 
Class I MHC restriction. In order for CTL to recognize target cells, the two 
populations of cells must share at least one class I MHC allele. Cattle have at least 
three class I MHC loci (1,2), and in order to measure the net lysis by all the CTL 
which recognize a virus, the CTL and target cells must be genetically identical at all 
class I MHC gene loci (26). The class I MHC restriction of CTL lysis means that in 
species of domestic livestock for which inbred lines do not exist, the most efficient 
method to measure CTL lysis is to isolate the CTL and the target cells from the 
same animal (6,10,11,26,30,50,51,53,54,78,81). In this way, both populations of 
cells are assured of being genetically identical, and thus matched at all class I 
MHC loci. 
Choice of target cells. A critical decision in measurements of CTL lysis is 
the choice of target cells. The most obvious consideration is that the isolation 
procedure cannot kill the animal, and it must leave the animal healthy enough to 
respond normally to challenge with the virus. The cells which are isolated must 
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have a high enough level of MHC expression for efficient antigen presentation to 
take place (6,14). Though the specific level of class I MHC expression in a target 
cell necessary for CTL lysis has not been defined, higher expressing cells are 
desirable (6). The target cells must also be permissive to infection by virus or to 
delivery of viral genes. 
Expression of viral genes. Another consideration in measurement of CTL 
lysis is how to express viral genes in target cells. CTL recognize peptides 
presented through the endogenous antigen presentation pathway, or the class I 
MHC pathway, so viral genes should be expressed endogenously in target cells. 
Sometimes the simplest way to do this is to infect the target cells with whole virus, 
and when it is possible, most CTL research examines lysis of virus-infected target 
cells (5,6,10,14,26,30,49,53,75,76). This method is not always possible, in that 
some viruses replicate at low or nonexistent titers in cultured cells which can 
obtained without killing the donor animal. For such viruses, an alternative method 
is to deliver viral genes to target cells via some vectored delivery system. This 
method is useful even for viruses which will infect cells in vitro, because many 
viruses which infect cultured cells lyse the cells they infect, and the viral lysis 
causes a background above which CTL lysis cannot be detected. Also, delivery of 
individual viral genes to target cells allows definition of the fine specificity of CTL to 
individual viral genes. 
Assessment of Cell-Mediated Immunity 
A variety of determinations of CTL lysis have been made in domestic animals 
using a number of technical variations on the basic measurement protocol outlined 
above. Still, a consistent and reliable method for testing this aspect of cell-
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mediated immunity for a variety of viruses has not been developed. A review of the 
techniques that have succeeded, their strengths, and their limitations is important in 
illustrating what is technically possible and in determining what further steps need 
to be taken to develop a bovine CTL assay. 
Humans and laboratory animals 
The techniques used in the determination of CTL lysis in domestic animals have 
usually been pioneered in laboratory animals and humans. 
Measurement of CTL responses in mice are greatly facilitated by the availability 
of inbred lines of mice. The MHC haplotypes are identical within inbred lines of 
mice and target cells from MHC-matched and MHC-mismatched lines can be used 
to show that the cytotoxicity is class I MHC restricted (11 ). Since target cells do not 
need to be isolated from the same animal as the CTL, cells like splenocytes can be 
used, even though their isolation kills the donor animal. Also, the cells can be 
transformed into cell lines, eliminating the difficulties associated with culture of 
primary cells. Because any cell which can be cultured in vitro can be used as a 
target cell, it is possible to perform a CTL assay with any virus that can be grown in 
cultured cells. 
Other strategies have been used in laboratory animals that are not available in 
inbred lines. Autologous skin fibroblasts from rhesus monkeys have been used as 
target cells (48). The fibroblasts were infected ex vivo with a retroviral vector 
encoding HIV-1 ENV/REV cDNA, and monkeys were then immunized with the 
fibroblasts. cos+ CTL were found to lyse autologous fibroblasts infected with the 
retrovirus vector or with vaccinia virus vectors carrying the HIV genes. In rhesus 
monkeys, autologous peripheral blood monocytes (PBMC) can be transformed in 
vitro with herpesvirus, and the immortalized cells can then be infected with other 
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viruses and used as target cells (83). Monkeys were vaccinated with a retroviral 
vector carrying a hepatitis B virus (HBV) core-neomycin phosphotransferase (NEO) 
fusion gene. CTL from the monkeys lysed autologous PBMC infected with the 
retroviral vector. The specific epitope recognized by CTL from vaccinated monkeys 
was found by coating panels of PBMC with synthetic HBV peptide subunits 
spanning the length of the core protein, and then using the peptide-coated cells as 
target cells. 
In humans, studies of HIV have primarily used Epstein-Barr virus (EBV)-
transformed B cells as the target cells in CTL studies. Transformed target cells are 
often infected with either whole HIV virus or with vaccinia virus carrying individual 
HIV genes or segments of genes (5, 11,51 ). Vaccinia virus constructs have allowed 
the localization of the CTL epitopes within the HIV genome. Though vaccinia virus 
is the most common gene delivery vehicle, a retroviral vector carrying HIV-1 Nef 
was successfully used in one study to measure a Net-directed CTL response which 
was confirmed by lysis of cells infected with a vaccinia-Net virus (69). 
Domestic animals 
Virus-specific CTL have been detected to vaccinia virus, maedi-visna virus 
(MVV), bovine respiratory syncytial virus (BRSV), Border disease virus, and bovine 
leukemia virus (BLV) in sheep (10,30,49,62,75,76,87), to caprine arthritic 
encephalitis virus (CAEV) in goats (50), to equine herpes virus type 1 and equine 
infectious anemia virus (EIAV) horses (12,53), to African swine fever virus (ASFV) 
in pigs (52,61 ), to feline immunodeficiency virus (FIV) in cats (26,78), to canine 
distemper virus in dogs (77), and to bovine herpes virus (BHV)-1, infectious bovine 
rhinotracheitis virus (IBRV), and parainfluenza type 3 (Pl-3) virus in cattle (6, 14,79). 
In addition, extensive work has been done to show class I MHC-restricted CTL 
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activity following infection with Thei/eria parva, an intracellular parasite (23,24,5S). 
A variety of target cells and gene delivery mechanisms have been used to arrive at 
these results. 
In goats infected with CAEV (50) and in sheep infected with MVV (10), 
autologous skin fibroblast lines were established from each animal. Skin cells 
were infected with virus and used to stimulate lymphocytes for one to two weeks, 
then 51 Cr-labeled skin cells were used as target cells. Autologous macrophage 
cultures were also established from sheep and infected with MVV (49). 
Autologous, infected target cells were lysed, but non-autologous or uninfected cells 
were not. Depletion of cos+ cells from lymphocyte pools resulted in an elimination 
of lysis. 
Autologous skin fibroblasts of sheep infected with vaccinia virus were killed by 
CTL from infected sheep (62). Ovine testis cells infected with BRSV have also 
been used as target cells, and were lysed by autologous, OvCDS+ CTL from BRSV-
infected lambs. Similar strategies have been used in cattle. Autologous skin 
fibroblasts and testes cells were isolated from calves, infected with IBRV, and used 
as target cells. Autologous skin cells were lysed by in vitro stimulated CTL, but 
testes cells were not. This study indicated that bovine testes cells did not function 
well as target cells (14). In another study using bovine coronavirus, testes cells 
were also ineffective as target cells (41 ). In cattle, fibroblastoid cells isolated from 
gluteal muscle and infected with whole virus were able to show cos+ CTL lysis in 
calves infected with Pl-3 virus between days six and nine post-infection (6). 
Autologous cells infected with whole virus were also used to show genetically-
restricted CTL activity against ASFV in swine (52), BHV-1 in cattle (79), equine 
herpes virus in ponies (12), and Border disease virus in sheep (S7). 
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Methods of viral gene delivery other than infection with whole wild-type viruses 
have also been successfully used in horses, sheep, and cats. Gene delivery has 
not yet been used in CTL measurements of cattle. 
In ponies infected with EIAV, autologous, virus-infected skin fibroblasts were not 
lysed by CTL when used as target cells. One kidney was isolated from each 
animal in the study, and autologous kidney cell cultures were established. 
Autologous EIAV-infected kidney cells were lysed by CTL from the infected ponies, 
indicating that although virus-specific CTL were present, the skin cells were 
ineffective as target cells. Removing COS+ cells from CTL removed the lytic activity. 
In the study, researchers mapped the specificity of the CTL using kidney cells 
infected with vaccinia viruses containing either an EIAV gag/5' pol gene segment 
or an env gene segment. Kidney cells infected with either recombinant vaccinia 
virus were lysed, indicating that the ponies possessed CTL recognizing epitopes in 
both regions of the EIAV genome. 
In sheep infected with BLV, autologous PBMC were used as target cells without 
addition of exogenous virus. Cells were stimulated by PHA blast and incubated 
overnight with 20-amino-acid-long subunits of the BLV gp51 protein. Cells were 
then labeled with 51Cr and were found to be lysed by autologous CTL. Using 
different combinations of peptide subunits, a ten-amino acid subunit of the gp51 
protein was found to be the target for COS+ CTL. 
In cats vaccinated with inactivated FIV virus and infected with live FIV, 
autologous skin fibroblasts infected with FIV were lysed by cos+ CTL. 
Researchers used autologous fibroblasts infected with recombinant vaccinia virus 
carrying either FIV gag or FIV env to determine if epitopes in either of the two genes 
were recognized, and were able to show different levels of CTL activity between 
the two groups of cats (26). 
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Finally, inbred lines of pigs, known as NIH miniature swine, have been bred 
which are homozygous at class I MHC loci. A nine-amino-acid-long CTL epitope to 
classical swine fever virus (CSFV) was mapped in these pigs, and the target cells 
used were nonautologous transformed kidney cells taken from other MHC-matched 
syngeneic animals. The epitope was found by using target cells infected with 
recombinant vaccinia viruses carrying different portions of the CSFV genome (61 ). 
Skin fibroblasts, macrophages, PBMC, testes cells, gluteal muscle cells have 
been infected with wild-type virus and used as target cells. Many of these cells 
were easy to isolate and culture, but in each case the choice of target cell was only 
applicable to the particular virus being studied because that virus was able to infect 
the target cells and many other viruses would not be able to infect them. 
Autologous PBMC have been coated with synthetic viral peptide subunits and used 
as CTL target cells. This method was able to quickly map CTL specificities to a 
short amino acid segment, but it is prohibitive because of the cost of synthesizing 
the peptides. Skin fibroblasts, transformed B cells, and kidney cells infected with 
recombinant vaccinia viruses carrying individual viral genes were used as CTL 
target cells. Vaccinia virus was able to infect a variety of cell types, and by carrying 
individual genes it can map CTL responses to specific regions of a viral genome. 
The main drawback of vaccinia virus vectors is that they are live replicating viruses 
and can themselves lyse infected target cells. Retroviral gene delivery has also 
been used with skin fibroblasts and transformed B cells to measure CTL 
specificities. The retroviral vectors had the advantages of vectored delivery, but did 
not lyse infected cells. The main drawback to the retroviral vectors was a lower 
level of gene expression than with live virus or vaccinia vectored viral genes. 
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Relationship to disease 
A major reason for the interest in cellular immunity is the role it plays in 
controlling disease. There is evidence that for many intracellular pathogens, CTL 
are sufficient to control disease and, for some, CTL are necessary. 
One of the most striking examples of the ability of CTL to control disease comes 
from research in cattle, not with a virus, but with the intracellular protozoan, 
Theileria parva. During part of its life cycle, this parasite lives inside B cells. It 
transforms the B cells and stimulates them to divide, which makes it relatively easy 
to obtain cultures of infected autologous B cells from cattle. A study was performed 
in which pairs identical twin cattle from split embryos were infected with a lethal 
strain of T. parva after one animal had been immunized against infection and the 
other had not. The immunized animals were protected against the infection and 
their naive twins began to sicken and die. Immunized animals were previously 
shown to possess class I MHC-restricted CDS+ lymphocytes capable of lysing 
autologous infected cells (5S). cos+ lymphocytes from the immunized animals 
were transferred to their dying twins, and within several days, the animals which 
received the transferred lymphocytes were able to control the infection and 
recovered (54). This study clearly showed that class I MHC-restricted CTL can be 
sufficient in conferring protective immunity against an intracellular pathogen. This 
is supported by a second study in which cattle immunized against one strain of T. 
parva were challenged with another strain. In all cases, animals which developed 
class I MHC-restricted CTL cross-reactive against both strains were protected, and 
animals which possessed CTL against only the immunizing strain were susceptible 
to heterologous challenge (S1 ). 
The importance of CTL in clearance of virus infection has been shown using 
knockout mice and adoptive lymphocyte transfer studies (13,32,36,43,46,64,66,74). 
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It appears that antibodies are the immune system's primary mechanism of 
protection against fast replicating, cytopathic viruses. These viruses enter cells and 
replicate to high enough levels that lysis only serves to release the viruses from 
cells. On the other hand, CTL are necessary in the control of slow replicating and 
noncytopathic viruses. CTL responses are quick enough to mount a response to 
slow replicating viruses before their replication is complete, and noncytopathic 
viruses would continue to produce virus from infected cells indefinitely if the cells 
were not lysed (40,89). 
In humans, a strong case has been made for the control of HIV infection by 
virus-specific CTL. In primary HIV-1 infection, patients which mount a strong CTL 
response to HIV the gp160 subunit of the env gene show a faster reduction of 
viremia and virus core antigenemia and a slower progression to disease than 
patients with a weak CTL response (11 ). It appears that the first effective antiviral 
immune response following HIV infection is mediated by CDS+ T cells (72). In the 
blood and lymph nodes of SIV mac -experimentally infected rhesus monkeys, virus-
specific CTL were detected before any virus-specific antibodies, and containment 
of acute viremia and antigenemia occurred about a week before neutralizing 
antibodies reached significant titers (67). High levels of HIV-specific CTL in 
humans are linked to lower viral load and slower progression to AIDS in both 
cross-sectional (68) and longitudinal (15,44,55,86) disease studies. CTL to the HIV 
Gag, Pol, and Env genes appear to be most effective at controlling infection (68). In 
summary, CTL appear to control initial HIV infection, high levels of CTL correlate 
with nonprogression, and the loss of CTL control coincides with progression to 
AIDS. CTL immunity seems to be very important in controlling HIV infection. 
In domestic animals, there is less compelling evidence of viral control by CTL, 
mostly because of the difficulties in measuring CTL lysis. A portion of cats 
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vaccinated with inactivated feline immunodeficiency virus (FIV) were protected 
against subsequent challenge with homologous FIV. The development of 
protective immunity in these cats was strongly correlated with the development of a 
class I MHC-restricted Env-specific CTL response (26). Sheep vaccinated with a 
recombinant vaccinia virus containing the gp51 portion of the bovine leukemia 
virus (BL V) env gene were protected from infection of BL V, and infected sheep 
were able to suppress further BL V replication after vaccination. There was no 
correlation between neutralizing antibodies and protection (59). In fact, protection 
conferred by the recombinant vaccine was correlated with a decrease in anti-gp51 
antibodies (31,63). In unprotected animals, antibody levels to gp51 increased for 
up to 16 months post-challenge and were ineffective in controlling virus titers (31 ). 
On the other hand, protection did correlate with the development of a COB+ CTL 
response against a conserved region of the BLV gp51 (30). These data provide 
evidence in support of control of viral infection by CTL in domestic animals. 
A necessary role in the control of virus infection has been shown for CTL in 
mice, and evidence supports the same role in humans, sheep, and cats. 
Conclusive evidence has been found to support the controlling role played by 
bovine CTL during T. parva infection. It is reasonable to infer that bovine CTL play 
a necessary part in controlling infection by some viruses, but determining which 
viruses are controlled CTL will require direct measurements of the CTL responses 
each virus elicits. 
Retroviral Gene Delivery 
One of the main components of a CTL assay is the method by which viral 
proteins are presented on the target cell surface. In some cases the simplest 
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method is to infect target cells with wild-type virus, but because of virus-induced 
lysis or an inability to infect cultured cells, a vectored gene delivery system is 
sometimes a more practical method of introducing viral genes into target cells. 
Several gene delivery systems have been successfully used in CTL assays. 
Vaccinia virus delivery is the most commonly used system, but retroviral vectors 
have also been used and they bring several advantages to a CTL assay system. 
Construction 
In retroviral gene delivery, cultured cell lines are used to produce hybrid virions 
which possess all the structural elements necessary for infection, but none of the 
genetic information to produce more viruses. The virions carry RNA transcribed 
from a synthetic plasmid into which any gene seven kilobases or smaller can be 
inserted. Thus, individual genes from any source, including a different virus, can 
be delivered by retroviral vectors. 
In order to achieve retroviral gene delivery, two components are necessary: a 
packaging cell line and a transfer vector. A packaging cell line contains the genes 
of a retrovirus and thus produces the structural proteins which can self-assemble 
into virus particles. Wild-type retroviruses contain a packaging signal which directs 
their incorporation into virions, but the retroviral genes in the packaging cell have 
had their packaging signal deleted. Thus, the virions that the packaging cell 
produces are empty and contain no genetic information. A transfer vector is a DNA 
plasmid which contains a retroviral packaging signal, an antibiotic resistance 
marker, and a site which can carry any inserted gene. When a packaging cell line 
is transfected with a transfer vector, the packaging signal directs the retroviral 
structural proteins to incorporate the transfer vector into virions. A packaging cell 
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line transfected with a transfer vector is called a vector-producer cell line since it 
produces retroviral vectors which will deliver the inserted gene upon infection. 
Advantages 
There are some benefits that are conferred by using retroviral vectors to deliver 
genes to target cells. Three important benefits are stable expression in infected 
cells, a wide range of cell types permissive to infection, and the absence of virus-
induced lysis in infected cells. 
In comparison to other methods of gene delivery, expression of retrovirus-
delivered genes is stable. After delivery by some other methods, genes are 
maintained in the cytoplasm or in endosomes and can be lost during rounds of cell 
division. Retroviruses integrate the genes they carry directly into the host cell 
chromosomes, and thus become a permanent feature of cells' genetic repertoire. 
Because the gene delivery is stable, a stock of retroviral vector-transduced target 
cells can be used for repeated assays of CTL activity without the variability in 
infection rates and expression levels caused by a different round of gene delivery 
for each CTL assay. 
The retroviruses used in · gene delivery have a wide host cell range. The 
retroviral env gene expressed by the packaging cell determines which cells are 
permissive to infection by the retroviral vector. Packaging cells are available with 
env genes which infect almost every mammalian cell which has been tested. This 
allows much more freedom in the choice of a target cell. 
Another major advantage to retroviral vectors is that they do not induce lysis in 
infected cells. After a defined period of time, many wild-type viruses cause lysis of 
infected cells, either through a breakdown in the cells' synthetic pathways or by 
expression of lytic viral genes. This virus-induced lysis can be a large source of 
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background during an assay meant to measure CTL lysis. In order to minimize the 
background, the assay must be performed after expression of viral genes and 
before cell lysis, a time-consuming optimization process for which a good 
compromise time cannot always be found. Since they do not induce lysis, retroviral 
vectors avoid the whole problem. 
Disadvantages 
Retroviral vector-mediated gene delivery has some drawbacks that can make it 
difficult to use. One common problem that occurs in vector-producer cell lines is 
recombination of the transfer vector. Transfer vectors are maintained in vector-
producer cell lines using a selectable marker on the plasmid. Retroviruses can 
undergo cycles of transcription of viral RNA and reverse transcription back into the 
host genome, and occasionally a recombination occurs with the inserted gene 
deleted and the selectable marker remaining. These recombinants possess an 
advantage over vector-producer cells with unaltered transfer vectors because the 
antibiotic resistance gene allows them to survive selection, but the energy saved by 
loss of the inserted gene may let them divide faster. The advantage is even greater 
if the inserted gene's product is somewhat toxic. Another problem that occurs in 
both packaging cells and infected cells is inactivation of one of the promoters in the 
retroviral vector. In this situation, the gene inserted into the transfer vector is 
partially silenced. A low level of transcription and thus antibiotic resistance may be 
maintained, but levels of the inserted gene's product will fall to undetectable levels. 
A third rather minor problem is a small number of restriction enzyme sites in the 
multiple cloning site of the available transfer vectors. This problem may soon be 
resolved with the availability of better plasmids, but does create difficulties at 
present. 
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Bovine Virus Model 
In order to test a bovine CTL assay system, it is necessary to chose a bovine 
virus which is likely to elicit a CTL response. Viruses which are noncytopathic in 
vivo or replicate slowly are more likely to be controlled by CTL in mice. Members of 
the lentivirus family, HIV, SIVmac• FIV, EIAV, CAEV, and MVV, have all been shown 
to elicit CTL responses during infection. Thus a good candidate for a model bovine 
virus to test a CTL assay is the lentivirus, bovine immunodeficiency virus (BIV). 
Bovine immunodeficiency virus 
BIV is a member of the retrovirus family and lentivirus subfamily of viruses. 
Retroviruses are diploid RNA viruses which undergo reverse transcription and 
integration into the host cell genome after entering a cell. The integrated viral 
genome is known as the provirus. The proviral genome structure of a simple 
retrovirus is shown in Figure 1. Long terminal repeats (L TRs) lie at both ends of the 
genome, with the 5' L TR acting as the promoter for the rest of the viral genome and 
the 3' L TR acting as a polyadenylation site. Three open reading frames between 
the L TRs encode the gag, pol, and env genes. The gag gene product, or the Gag 
polyprotein, is proteolytically cleaved into three proteins: matrix (MA), capsid (CA), 
LTR 
Figure 1. Proviral genome of a simple retrovirus (Moloney murine leukemia virus). 
The large arrows represent genes. The small arrow indicates that the 
L TR acts as the promoter for the provirus. 
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and nucleocapsid (NC). The BIV CA protein is a 26 kDa molecule which 
assembles into the hydrophobic virion core. It is the most abundant protein in the 
virion. The MA and NC proteins are 16 kDa and 15 kDa in size, respectively, and 
are responsible for association of the virion core with the cell membrane and the 
viral RNA genome, respectively. The Pol protein is cleaved to form viral proteinase 
(PR) , reverse transcriptase (RT) and integrase (IN) enzymes. The PR protein 
cleaves the Gag and Pol polyproteins, the RT enzyme uses viral genomic RNA as a 
template for synthesizing double-stranded DNA, and the IN protein integrates the 
viral DNA into the host cell chromosome. The env gene product is a glycoprotein 
which is cleaved by a host cell protease into a surface glycoprotein (SU) and a 
transmembrane glycoprotein (TM). The SU protein is responsible for binding a 
receptor on the host cell plasma membrane, and the TM protein anchors the Env 
complex in the viral envelope and induces fusion of the viral envelope with the host 
cell membrane (39). 
Retroviruses are divided into the oncovirus, lentivirus, and spumavirus families. 
Lentiviruses are non-oncogenic viruses characterized by genomic organization, 
virus morphology, and in some cases by a slow, progressive disease that 
eventually leads to wasting and death. In Latin, lenti means slow, thus the name 
lentivirus. The lentiviral genome differs from that of simple retroviruses with an 
additional three to six accessory proteins. Two accessory proteins, Tat and Rev, 
temporally regulate the expression of viral genes. After reverse transcription and 
integration, the lentiviral provirus produces a full length RNA which is multiply 
spliced to form tat and rev RNAs. Tat upregulates transcription, and Rev facilitates 
the nuclear export of singly spliced and unspliced RNAs from which Gag, Pol, and 
Env can be translated. This regulation pattern allows proviruses to lie essentially 
dormant inside cells for long periods of time after infection (39). 
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Some common aspects of pathology are shared by different lentiviruses. 
During primary infection, the virus undergoes rapid replication and proliferation in 
lymphocytes or macrophages. This initial proliferative stage is usually controlled 
after several days or weeks by the immune system, but the infection is not cleared 
and detectable virus replication persists. In HIV or maedi/visna virus (MVV) of 
sheep for example, initial productive infection is followed by an asymptomatic 
incubation period of months to years. During the incubation period, viruses 
continue to replicate and the continuous onslaught on the cells of the immune 
system may result in a chronic wasting syndrome which can eventually lead to 
cachexia and death. 
The animal from which BIV was originally isolated showed persistent 
lymphocytosis, lymphoid hyperplasia, and perivascular cuffing in the brain (84). 
Experimental infection with BIV was shown to cause follicular hyperplasia of lymph 
nodes and a transient lymphocytosis in infected calves (16). BIV infection elicits 
detectable antibody responses. Antibodies to subunits of the Gag (CA) and Env 
(Env8 portion of TM) were detected in cattle 4 weeks post-infection. By 40 weeks 
post-infection, serum antibody levels to the CA protein had gradually disappeared 
in 7 out of 8 cattle (37). In HIV infection, loss of Gag-specific antibodies is 
associated with disease progression to AIDS (3,8, 18,33,47), but BIV-infected cattle 
remained healthy during and after loss of Gag antibodies. The cattle remained 
infected and circulating virus could be isolated from the peripheral blood of all 
animals, but none developed clinical disease. This suggested that antibodies to 
Gag were not a major factor in controlling BIV in experimentally-infected cattle. It is 
possible that virus neutralizing antibodies are responsible for controlling virus 
replication. However, studies in our laboratory have shown an inverse relationship 
between neutralizing antibody titer and frequency of virus recovery: animals with 
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higher neutralizing titers had a higher frequency of virus isolation (17). Together, 
these data suggest that the humeral immune system plays only a minor, or 
supporting, role in control of BIV replication in vivo. This observation, in 
conjunction with the detection of CTL in every other lentiviral infection that has 
been tested, makes BIV-infected cattle good candidates for models to use in a CTL 
assay. 
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MATERIALS AND METHODS1 
Development of a Bovine CTL Target Cell 
Culture of cells 
The primary cell cultures used in this research were derived from bovine fetal 
testes (BOTEST), fetal turbinate (BOTUR), fetal skin (BOSK), fetal tongue 
(BOTONG), embryonic kidney (EBKp), fetal lung (FBL), adult pulmonary artery 
endothelium (CPAE, ATCC #CCL-209), and adult peripheral blood adherent cells 
(PBAC). Immortal cultured cell lines used were SV40-transformed bovine 
macrophages (BOMAC, kindly provided by Judy Stabel) (20), bovine adrenal 
medullar endothelial cells (EJG, ATCC #CRL-8659), Madin-Darby bovine kidney 
epithelial cells (MDBK, ATCC #CCL-22), mouse fibroblasts (NIH/3T3, ATCC #CRL-
1658), human cervical carcinoma epithelial cells (HeLa, ATCC #CCL-2), and 
adenovirus-transformed human kidney cells (293 cells, a subpopulation derived 
from ATCC #CRL-1573 kindly provided by Tom Hope). Packaging cell lines used 
were PA317 (ATCC #CRL-9078) and PG13 (ATCC #CRL-10686). The vector-
producer cell line PG13/LNc8 (ATCC #CRL-10685) was also used. 
All cells except CPAE were cultured in DMEMt with 10% FBS. CPAE were 
cultured in DMEM with 20% FBS. All cells except 293 cells were passed by 
trypsinizing cells for one to five minutes, then inactivating the trypsin by addition of 
media containing serum and transferring cells to new flasks. The 293 cells were 
passed by removing the old media, vigorously washing cells off of their adherent 
1 The recipes for most of the solutions listed in this chapter are located in Appendix 
A, and all such solutions are marked with a t symbol the first time they are 
mentioned in the text. The expanded forms of many abbreviations can be found in 
Appendix B. 
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surface using fresh media, and placing cells in new flasks which had been treated 
for at least three hours at 4°C with 0.1 % gelatin. 
Isolation of primary cells 
Cells were cultured from different tissue by several different techniques by 
Lawrence Elsken's laboratory at NVSL (Ames, Iowa) and Janice Miller's laboratory 
at NADC (Ames, Iowa). Bovine testes, bovine tongue, bovine turbinate, and bovine 
kidney cells were isolated from their respective tissues in fetal calves at NVSL. 
Cells were released from the tissue by trypsinization, grown in MEM with Earle's 
salts, and then frozen in liquid nitrogen as BOTEST, BOTONG, BOTUR, and EBKp 
cultures. The membrane was removed from fetal bovine lung, cells were released 
by trypsinization, grown in culture, and frozen in liquid nitrogen as FBL cultures at 
NADC. Cells from bovine fetal skin explants were grown in culture in Lawrence 
Elsken's laboratory, and frozen in liquid nitrogen as BOSK cultures. 
PBAC were isolated from cultures of adherent peripheral blood mononuclear 
cells (PBMC). Blood was drawn from cattle by jugular venipuncture using either 
EDTA or ACD as an anticoagulant. The blood was centrifuged at 400 x g for 30 
minutes to separate plasma and red blood cells (RBC). The buffy coat at the 
interface was collected. Two volumes of RBC Lysis buffert were added, the mixture 
incubated for about 1 minute, and one volume of Restoring buffert was added. 
Cells were pelleted at 150 x g for 10 minutes, and the cell pellet resuspended in 
PBS. Two volumes of RBC Lysis buffer were added for one minute, then one 
volume of restoring buffer was added. Cells were again pelleted for 1 O minutes at 
150 x g and resuspended in PBS. Cells were seeded in tissue culture flasks for 24 
to 48 hours, then non-adherent cells were removed by washing the cultures with 
HBSSt, and media was replaced. The media was changed weekly. After three 
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weeks, a much larger cell type with prominent cytoplasmic striations when viewed 
under phase could be seen to be outgrowing monocytes in some cultures. These 
cells, termed PBAC, were trypsinized and passed. After three passages, PBAC 
were frozen in liquid nitrogen. 
Measurement of class I MHC expression 
Cell cultures were grown to confluency in 75 cm2 flasks. Cells were trypsinized 
with STV and passed into two or three 75 cm2 flasks, so all cells would be dividing. 
The next day, media was removed from the sub-confluent cultures and replaced 
with PBS containing 0.5 mM EDTA and cells were scraped off the flask after five to 
ten minutes. Duplicate flasks were pooled and each cell type was seeded in wells 
of a 96-well plates. The plates were centrifuged briefly to pellet the cells, the 
supernatant was removed and cells were washed once in FACS buffert. Cells 
were again pelleted and thoroughly resuspended in 50 µI of FACS buffer or 50 µI 
of VMRD monoclonal antibody H58A (specific for the heavy chain of bovine class I 
MHC) diluted 1 :200 in FACS buffer. Cells were incubated for 20 minutes on ice. 
After primary antibody incubation, cells were pelleted and washed in FACS buffer 
three times. Cell pellets were resuspended in either 50 µI FACS buffer or 50 µI 
FITC-conjugated goat antibody to mouse lgG diluted 1 :200 in FACS buffer. Cells 
were incubated 20 minutes on ice in the dark in secondary antibody. After 
incubation, the cells were pelleted and washed in FACS buffer three times. Cells 
were finally resuspended in 500 µI FAGS buffer and their level of fluorescence 
measured in a Coulter Epics XL-MCL flow cytometer. Cells left untreated with 
antibodies and cells treated with only the secondary antibody were used as 
controls. Staining and FAGS analysis was performed on two separate occasions 
with all cell types analyzed on both occasions. The non-specific reactivity of the 
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secondary antibody for each cell type was assessed as the difference between the 
mean fluorescence (mean fluorescent channels) of the secondary only-labeled 
cells and the unstained controls. The MHC-specific fluorescence is calculated as 
the difference between the mean fluorescence of class I MHC-labeled cells and the 
mean fluorescence of secondary only-labeled cells. 
Titering of PG13/LNcB retrovirus 
The PG 13 cell line produces a pseudotyped retrovirus with Moloney murine 
leukemia virus (MoMLV) core proteins and gibbon ape leukemia virus (GaLV) 
envelope glycoproteins. The PG 13/LNc8 cell line contains the LN transfer vector, 
which has a gene for neomycin resistance between two MoML V L TRs. The 
retroviruses produced by the PG 13/LNc8 cell line deliver the neomycin resistance 
gene to cells (56). 
A virus stock was made from PG13/LNc8 supernatant. Two 75 cm2 flasks of 
PG 13/LNc8 cells were grown to confluency. The old media in each flask was 
discarded and replaced with 10 ml of fresh media. Thirty-two hours later, the 
supernatant from the two flasks was collected and pooled. The pooled media was 
clarified for 10 minutes at 1800 x g, and aliquots were stored at -80°C. 
To test for susceptibility to infection with PG13 recombinant virus, cells were 
passed into 6-well plates to produce approximately 40% confluency after one day 
of growth (2.5x104 to 1.5x105 cells per well). The day after passage, media was 
replaced with 1 ml of LNc8 virus stock at 10-fold serial dilutions in media with 
8 µg/ml polybrene. Dilutions were made from 10° to 10-4 ml virus stock per ml 
media. After 28 to 36 hours, the virus stock was replaced with normal media 
containing 1.5 mg/ml G418 (active) to select for neomycin-resistant cells. Between 
5 to 10 days of G418 selection were sufficient to kill uninfected control cells and for 
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infected cells to form resistant colonies. At that time, colonies were fixed and 
stained by incubating cells for 5 minutes in 0.1 % methylene blue in methanol/water 
(1 :1 vol./vol.). Blue colonies were counted and the number of neomycin-resistant 
colony-forming units (cfu) per ml of virus stock was calculated. Virus titrations were 
performed for each cell culture at least twice. 
lmmunocytochemistry (ICC) 
Cultured cells were tested for various proteins by ICC. Cells were washed once 
with TNFBSt, then fixed with ice-cold methanol for five minutes. Methanol was 
diluted 1 :1 with TNFBS and removed, and cells were washed twice with TNFBS. 
Cells were incubated for thirty minutes with the primary antibody at room 
temperature with rocking, and washed three times with TNFBS. The HRP-
conjugated secondary antibody was added, and cells were incubated for thirty 
minutes at room temperature with rocking. The secondary antibody was removed 
and cells were washed three times with TN. HRP substrate was added, and cells 
were incubated for nineteen minutes in the dark at room temperature. The HRP 
substrate was removed, and cells were washed with tap water and allowed to dry. 
Cells were examined by brightfield microscopy for reddish-brown staining, 
indicating a positive reaction. 
lmmunofluorescence assay (IFA) 
Cultured cells were tested for various proteins by IFA. Cells were washed once 
with TNFBS, then fixed with either ice-cold methanol for five minutes or with 
formaldehyde/Triton X-100 as follows. Cells were fixed with 3. 7% formaldehyde in 
PBS for 20 minutes at room temperature. Formaldehyde was removed, and cells 
were washed twice with TNFBS. In some cases, cells were permeabilized with 
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0.5% Triton X-100 for 15 minutes at room temperature. Triton X-100 was removed, 
and cells were washed three times with TNFBS. Cells were incubated in primary 
antibody for thirty minutes at room temperature with rocking. Primary antibody was 
removed, and cells were washed three times with TNFBS. The FITC-conjugated 
secondary antibody was added to cells and incubated in the dark for thirty minutes 
at room temperature with rocking. The secondary antibody was removed and cells 
were washed three times with TN. Cells were examined by fluorescent microscopy 
while in the TN buffer. If necessary, cells were stored in a light-proof box at 4°C for 
later examination. 
Dil-Ac-LDL uptake 
Some cells were tested for the presence of the "scavenger cell pathway" by 
measuring uptake of Dil-Ac-LDL. Ac-LDL is taken into cells via the pathway, and 
the Oil label accumulates in cholesterol deposits in the cytoplasm (85). The media 
from cells was replaced with normal media containing 5 µg/ml Dil-Ac-LDL, and 
cells were incubated at 37°C and 7% C02 for one hour. Dil-Ac-LDL media was 
then removed, and cells washed several times with probe-free media. Cells were 
visualized by fluorescent microscopy using standard rhodamine excitation: 
emission filters. Uptake was indicated by bright reddish-orange deposits of the dye 
in the cytoplasm of cells. Quantitation of the fluorescence was carried out by FACS 
analysis. Cell were trypsinized with STVt, then the trypsin was inactivated by 
adding normal media containing serum. Cells were pelleted by centrifugation, the 
supernatant removed, and cells resuspended in FACS buffer. The fluorescence of 
Oil-labeled cells and unlabeled control cells was analyzed on a Coulter Epics XL-
MCL flow cytometer. The level of fluorescence was analyzed as the mean 
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fluorescence of labeled cells minus the mean fluorescence of unlabeled cells. Dil-
Ac-LDL uptake measurements were performed in triplicate. 
Lymphocyte binding assay 
A characteristic of high endothelial cells is their ability to bind freshly isolated 
lymphocytes. Several cell cultures were tested for lymphocyte binding. Bovine 
peripheral blood mononuclear cells (PBMC) were obtained by a buffy coat isolation 
of blood in the same manner as for PBAC isolations. Approximately 3 x 106 PBMC 
were added per well cultured cells and incubated for 2 hours at 37°C and 7% C02 • 
After incubation, the slides were immersed in PBS, and the chamber dividers 
removed. Cells were washed three to four times to remove unbound lymphocytes 
by rocking the PBS bath and changing the PBS after one to two minutes. Cells 
were fixed by in 3. 7% formaldehyde in PBS for 20 minutes, and bound 
lymphocytes were detected by IFA using an anti-CD45 mouse monoclonal 
antibody (VMRD), and a FITC-conjugated goat anti-mouse secondary antibody. 
The number of lymphocytes bound to 100-110 cultured cells was counted, and the 
number of lymphocytes bound per cultured cell was calculated. Only lymphocytes 
which had spread out upon a cultured cell were counted; lymphocytes which 
remained rounded were not counted because many rounded lymphocytes were 
also non-specifically bound to the bottom of the flask. 
Construction of Retroviral Vectors 
Polymerase chain reaction (PCR) 
Briefly, 5 to 25 ng of template DNA were put in 100 µI of solution with final 
concentrations of 1 X PCR Buffer II (Perkin-Elmer), 1.5 mM MgCl2 , 200 µMeach of 
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deoxyadenosine triphosphate, deoxyguanosine triphosphate, deoxycytosine 
triphosphate, and deoxythymidine triphosphate (dNTPs), 1 µM of each primer, and 
2.5 units of Taq polymerase. Each reaction mixture was incubated at 94°C for 2 
minutes, 50°C for 1 minute, and 72°C for 6 minutes, then for 30 cycles of 94°C, 
50°C, and 72°C each for 1 minute, and one final cycle at 94°C and 50°C for 1 
minute and 72°C for 4 minutes, after which reactions were cooled to 5°C. 
The size and number of PCR products were assessed by agarose gel 
electrophoresis. PCR products were electrophoresed through 1 % agarose gels in 
TAE buffert. The gel was stained in 1.5 µg/ml ethidium bromide for 10 to 15 
minutes and destained in water for 10 to 15 minutes. DNA bands were visualized 
by placing stained gels on an ultraviolet lamp. 
Reverse transcription-polymerase chain reaction {RT-PCR) 
RNA samples were analyzed with RT-PCR similarly to PCR analysis, but with a 
preceding DNase treatment and reverse transcription step. Each 20 µI DNase 
reaction contained 5 mM MgCl2, 1 X PCR Buffer II, 1 mM of each dNTP, 2.5 µM 
random DNA hexamers, 20 U of RNase Inhibitor, 1 U of RNase-free DNase I, and 
up to 1 µg of total cellular RNA. Each reaction mixture was incubated at 37°C for 
30 minutes, 75°C for 5 minutes, and then cooled to 4°C. Keeping the reaction 
tubes on ice, 50 U (1 µI) of MLV reverse transcriptase was added to each reaction 
mixture. Reverse transcription was carried out at 42°C for 45 minutes, 99°C for 5 
minutes, and 5°C for at least 5 minutes. The reaction volume was then brought up 
to 100 µI and final concentration of reagents adjusted to 1 X PCR Buffer II, 2 mM 
MgCl2, 200 µM of each dNTP, 1 µM of each primer, and 2.5 units of AmpliTaq 
polymerase. PCR amplification temperatures and times were the same as for PCR. 
32 
RT-PCR products were analyzed by agarose gel electrophoresis and ethidium 
bromide/UV visualization. 
Cloning of PCR products into bacterial plasmids 
Taq PCR products possess an overhanging adenosine at each of their 3' ends. 
These overhangs were used to clone PCR products into three different bacterial 
plasmids, pCRll, pGEM-T, and pCR3. The pCRll vector (lnvitrogen) is a bacterial 
plasmid linearized with a cut in the middle of a betagalactoside (B-gal) gene and 
which possesses 5' thymidine triphosphate overhangs on each terminus. Ligating 
a PCR product into the plasmid will disrupt the B-gal gene and transformed 
bacterial colonies will be yellowish-white; plasmids which self-ligate without a PCR 
product will maintain a functioning B-gal gene and will produce blue colonies. PCR 
products were also ligated into pGEM-T, a B-gal disruption plasmid sold by 
Promega which is similar to pCRll. The pCR3 vector is linearized downstream of a 
cytomegalovirus (CMV) promoter and allows expression of ligated PCR products in 
eukaryotic cells. In a 10 µI reaction, 1 to 2 µI of PCR product were combined with 1 
µI 10X ligation buffer (supplied by manufacturer), 50 µg linearized pCRll, pGEM-T, 
or pCR3 vector, and 4 units of T4 DNA ligase. The ligation reaction was carried out 
overnight at 15°C. 
Transformation of E. coli 
Competent E. coli were transformed with bacterial plasmids using a method by 
Hanahan (34). A culture of DH5a-strain E. coli cells was grown overnight in NZY 
brotht; 1.5 ml was inoculated into 25 ml of sost and grown for 2 to 2.5 hours. Cells 
were pelleted by centrifugation at 4200xg, resuspended in 8 ml TFBt and 
incubated on ice for 10 to 15 minutes. Bacteria were pelleted again and 
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resuspended in 2 ml TFB. Seventy µI of DMF were added, cells were chilled on ice 
for 5 minutes, 4 µI of B-mercaptoethanol added, cells iced for 10 minutes, 70 µI 
DMF added, and cells iced once more for 5 minutes. In ice-cold Falcon 2059 
tubes, 210 µI of the bacterial cell suspension were added to 1-2 µI of ligated DNA 
and 8-9 µI of SOB, and the mixture was incubated on ice for 30 min. Cells were 
heat shocked at 42°C for 90 seconds, chilled on ice for 90 seconds, and then 0.8 
ml of SOCt were added. The cells were incubated at 37°C with 225 rpm shaking 
for one hour. Bacteria were spread on YT-carbenicillin platest and grown 
overnight at 37°C. All plasmids used in this study possessed a gene for ampicillin 
resistance, and the carbenicillin antibiotic in the plates selects bacteria transformed 
with plasmid. When plasmids contained the B-gal gene, YT-carb plates were pre-
treated with 25 µI of 40 mg/ml X-Gal and 8 µI of 100 mM IPTG to produce blue and 
white colonies. 
Plasmid isolation preparations 
Quantities of plasmid were obtained from transformed E. coli by growing large 
quantities of the bacteria, separating plasmid DNA from chromosomal DNA, and 
then removing protein. One bacterial colony was used to inoculate 10 ml of Super 
Brotht containing 100 µg/ml ampicillin, and incubated overnight at 37°C and 225 
rpm shaking. Bacteria were pelleted in 3 ml aliquots by centrifugation and the 
supernatant removed. Bacterial pellets were resuspended in 200 µI IH Buffer 1t. 
Bacteria were lysed by adding 300 µI of a 0.2 N NaOH/1 % SOS solution and 
incubating on ice for 5 minutes. Lysis was halted and chromosomal DNA 
precipitated by adding 300 µI of 3.0 M potassium acetate (pH 4.8) and icing for 5 
minutes. Cellular debris was pelleted by a 10 minute centrifugation at 15,000xg 
and discarded. The supernatant was added to 2 µI of 10 mg/ml RNase A and 
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incubated at 37°C for 20 minutes. Protein was extracted from the supernatant 
solution three times by adding 400 µI chloroform, vortexing 30 seconds, 
centrifuging for 2 minutes, and collecting the top, aqueous phase. Plasmid DNA 
was precipitated by adding an equal volume of isopropanol and centrifuging at 
15,000xg for 15 minutes. The DNA pellet was washed with 500 µI of 70% ethanol 
and centrifuged for 2 minutes. The ethanol supernatant was discarded, the DNA 
pellet dissolved in water, and traces of ethanol removed by 3 minutes of vacuum 
centrifugation. Plasmid DNA was again precipitated by adding 8 µI of 4 M NaCl 
and 40 µI of 13% PEG8000 , incubating on ice for 30 minutes, and centrifuging for 20 
minutes at 4°C. The supernatant was removed, the pellet of purified plasmid DNA 
was rinsed with 70% ethanol and resuspended in 23 µI 0.1 X TEt, and ethanol 
traces were evaporated by vacuum centrifugation. 
In some cases, plasmid preparation was performed using an affinity column 
DNA purification kit. Bacteria were lysed under alkaline conditions, then returned 
to normal pH, and the plasmid-bearing supernatant was removed from the 
precipitate of cellular debris and added to an affinity column containing an anion-
exchange resin (manufactured by Qiagen). RNA, proteins, and other low molecular 
weight contaminants were separated from DNA using different molarity salt solution 
to wash the column. DNA was precipitated from solution by adding 0.7 volumes of 
isopropanol and centrifuging at 15,000xg for 30 minutes. The supernatant was 
discarded and the pellet washed with 70% ethanol and resuspended in 0.1 X TE. 
Subcloning of DNA fragments between plasmids 
DNA fragments were sometimes transferred from a source plasmid into a 
destination plasmid. Fragments were excised from the source plasmid by 
restriction enzyme digestion using at least 5 units of enzyme per microgram of 
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plasmid. Restriction enzyme digestion was carried as per manufacturer 
instructions, usually in a 1X buffer (supplied by the manufacturer) at 37°C for 2-3 
hours. All subcloning performed in this research made use of two different 
restriction enzyme sites on either side of the excised fragment. The entire digestion 
reaction was then electrophoresed in a 1 % agarose gel at a low voltage overnight. 
The gel was stained in 1.5 µg/ml ethidium bromide and visualized on a UV lamp. 
The band containing the desired fragment was excised from the gel, and a 2.5% 
low-melting-temperature agarose containing 0.2-0.4 µg/ml ethidium bromide was 
cast around the excised piece of 1 % agarose. The DNA was electrophoresed out 
of the 1 % agarose in the low-melting-point agarose, and the new DNA band 
excised from the gel. The DNA was isolated from the agarose using a Wizard DNA 
Purification kit (Promega). The gel fragment was melted at 70°C, then 1 ml of 
Wizard Prep resin was added and mixed gently for 20 seconds. The slurry was 
pushed through a Wizard Minicolumn with a syringe, washed with 2 ml of 80% 
isopropanol, and the DNA eluted with 50 µI 1 X TE. The restriction enzyme DNA 
fragment was stored at -20°C until ready for ligation. 
The destination plasmid was prepared by digesting with one of the two 
restriction enzymes. Complete linearization was verified by agarose gel 
electrophoresis. The DNA was then separated from the restriction enzyme by 
adding an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1 ), vortexing 
for 30 seconds, and centrifuging at 15,000 x g for 5 minutes. The top, aqueous 
layer was transferred to a clean tube and 0.1 volumes of 3 M sodium acetate (pH 
5.2) and 2.5 volumes of 95% ethanol were added. The DNA was precipitated 
overnight at -20°C, then pelleted for 15 minutes at 15,000 x g and 0°c. The pellet 
was washed with 70% ethanol, and redissolved in 0.1 X TE. The DNA was then 
similarly digested with the second restriction enzyme and purified by 
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phenol/chloroform extraction follow by ethanol precipitation. Finally, the 5' terminal 
phosphate groups were removed from the linearized destination plasmid to prevent 
self-ligation. A reaction of the DNA, 1 X dephosphorylation buffer, and 1 U calf 
alkaline phosphatase was incubated at 37°C for 30 minutes. A solution of 0.2 M 
EDTA was added to final concentration of 5 mM and the mixture incubated at 65°C 
for one hour. The reaction was allowed to cool, and the DNA was extracted with an 
equal volume of phenol. The top phase was transferred to a clean tube and the 
DNA again extracted with an equal volume of phenol/chloroform/isoamyl alcohol 
(25:24:1 ). The top, aqueous phase was transferred to a clean tube, and the DNA 
was precipitated overnight with sodium acetate and ethanol, washed with 70% 
ethanol, and resuspended in 1 X TE. 
The destination plasmid was then ligated with the excised DNA fragment. A 20 
µI solution with 15-30 fmol of the destination plasmid, 45-90 fmol of the DNA 
fragment, 1X ligase buffer (supplied by manufacturer), and 1 U of T4 DNA ligase 
was incubated overnight at 14°C. One microliter of 0.5 M EDTA was added to 
inactivate the ligase, and the DNA was used to transform competent E. coli. A 
ligation reaction without the DNA fragment was used as a control to test for 
excessive self-ligation of the destination plasmid. Transformed bacteria were 
tested for the DNA fragment by colony blot hybridization, or if the amount of self-
ligation was very low, plasmid was immediately isolated from colonies and tested 
by restriction enzyme digestion/agarose gel electrophoresis. 
Southern blot hybridization 
For a more sequence-specific analysis, DNA electrophoresed through an 
agarose gel was often transferred to a nylon membrane. The gel was agitated for 
30 minutes in Southern I Buffert twice. The DNA was then blotted from the gel onto 
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a Hybond-N nylon membrane overnight using Alkaline Transfer Buffert as the 
wicking solution. The membrane was air dried, and its DNA crosslinked for 5 
minutes on a UV lamp. Membranes were hybridized with radioactive DNA probes. 
DNA probes labeled with 32P were made by random primed synthesis. Briefly, a 
20 µI reaction mixture with 20 ng of template DNA, 1 X hexanucleotide reaction 
buffer (Boehringer-Mannheim), 25 µMeach of dATP, dCTP, and dGTP, 20 µCi a-
32P-dTTP (200-800 Ci/mmol), and 0.5 U Kienow DNA polymerase was incubated at 
37°C for 30 minutes. Then, 78 µI of 1X TE and 2 µI of 0.2 M EDTA were added, and 
1 µI of the mixture was dotted onto each of two DE81 filters. The probe was 
incubated in boiling water for five to ten minutes and iced for five to ten minutes. 
The percent incorporation of the radioactive dTTP into the probe was determined 
by washing one of the two DE81 filters three times for five minutes in 0.35 M 
Na2HP04 buffer, and dividing the radioactive counts per minute (cpm) of the 
washed filter by the unwashed filter. No probes with percent incorporations below 
60% were used, and thus all probes had a specific activity of at least 5 x 108 
dpm/µg. Before addition of the probe, DNA membranes were prehybridized for at 
least one hour at 65°C in 50 ml of DNA pre-hybridization solution. DNA pre-
hybridization solution consisted of 3X SSPE, 5X Denhardt's reagentt, 0.1 % SOS, 
and 100 µg/ml denatured, sheared salmon sperm DNA. After pre-hybridization, the 
radiolabeled DNA probe was added to 5-10 ml of the pre-hybridization solution, the 
remainder of the pre-hybridization solution was discarded, and the DNA membrane 
was incubated in the radioactive solution overnight at 65°C. After the overnight 
hybridization, the membrane was rinsed three times in 2X SSPE + 0.1 % SOS, and 
incubated for thirty minutes at 65°C in 2X SSPE + 0.1 % SOS. Another set of three 
rinses and thirty minute incubation was performed in 0.1 X SSPE + 0.1 % SOS. 
Finally, the membrane was rinsed two times in 2X SSPE + 0.1 % SOS and exposed 
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Kodak X-Omat X-ray film for various lengths of time to generate autoradiographs of 
the DNA. 
A radioactive probe was sometimes stripped from a membrane so that the 
membrane could be hybridized with a different probe. This involved pouring 
boiling 0.1 % SOS over the membrane, and letting it cool to room temperature. Two 
or three SOS treatments were usually sufficient to remove all radioactivity from 
membranes. 
Bacterial colony blot hybridization 
An agar plate of bacterial colonies was sometimes blotted onto nylon filters in 
order to screen the colonies containing specific DNA sequences. A circular 
Hybond-N nylon membrane was laid on each agar plate, then removed. 
Membranes were laid upon Whatman paper soaked with 0.5 M NaOH for 5 
minutes, air dried for 5 minutes, and again laid on 0.5 M NaOH Whatman paper for 
5 minutes. Membranes were rinsed three times for 5 minutes in 2X SSPEt + 0.2% 
SOS, air dried, and their DNA crosslinked for 5 minutes on a UV lamp. Membranes 
were hybridized with radioactive DNA probes in the same manner as in Southern 
blot hybridization. 
Calcium phosphate transfection of cultured cells with DNA plasmids 
Cells were passed the day before transfection to give 30-80% confluency. The 
media was changed about an hour before DNA was added. A 250 µI reaction 
mixture of DNA (up to 15 µg) and 250 mM CaCl2 was added dropwise to 250 µI 2X 
HBSt with low speed vortexing. The mixture was allowed to incubate for 15-20 
minutes until a fine white precipitate was visible in suspension. The DNA 
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precipitate was added dropwise to the cultured cells, and allowed to incubate for 
three hours at 37°C and 7% C02 • The media was then removed, the cells washed 
with HBSS + 2% FBS, and 15% glycerol in HBS was added to for 2 minutes. The 
HBS-glycerol was removed, the cells washed once more in HBSS + 2% FBS, and 
cells were refed with fresh media. 
Analysis of Gene Delivery and Expression 
Isolation of RNA from cultured cells 
RNA was extracted from cells using a kit from Stratagene. Approximately 1 ml 
of a guanidinium thiocyanate/B-mercaptoethanol solution was added per 75 cm2 of 
growth area for thirty seconds with rocking to dissolve cells and inactivate RNases. 
To 1 O ml of dissolved cells, 1 ml of 2 M sodium acetate (pH 4.0) was added and 
gently mixed, 1 O ml of water-saturated phenol (pH 5.5) was added and gently 
mixed, and 2 ml of chloroform:isoamyl alcohol (49:1) was added and vigorously 
mixed. The solution was incubated on ice for 15 minutes, then centrifuged at 
10,000 x g for 20 minutes at 4°C. The upper aqueous phase was transferred to a 
clean tube, mixed with an equal volume of isopropanol, the RNA precipitated at -
20°C for at least one hour, and again centrifuged at 10,000 x g for 20 minutes at 
4°C. The supernatant was discarded and the RNA pellet dissolved in 3 ml of 
guanidinium thiocyanate/B-mercaptoethanol solution. Three ml of isopropanol 
were added, and the RNA was again precipitated at -20°C for at least one hour. 
The RNA was pelleted at 10,000 x g for 10 minutes at 4°C and the pellet washed 
with 70% ethanol. The pellet was dissolved in 60 µI of DEPC H2Qt and stored at -
70°C. 
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Northern blot hybridization 
RNA to be analyzed by Northern blotting was mixed with an equal volume of 
Ambion's Gel Loading Buffer ut and denatured at 80°C for 5 minutes. The 
denatured RNA was electrophoresed in a 1 .2% agarose/formaldehyde gelt at 50 V 
(5 V/cm) for about 3 hours. The gel was agitated for 1 O minutes in DEPC H20 
twice, and the RNA visualized on a UV lamp. The gel was agitated for 20 minutes 
in 0.05 N NaOH, rinsed briefly in DEPC H20 twice, and agitated for 45 minutes in 
20X SSCt. RNA was blotted from the gel to a Hybond-N nylon membrane 
overnight with 20X SSC as the wicking solution. The membrane was air dried, and 
its RNA crosslinked for 5 minutes on a UV lamp. Membranes were hybridized with 
radioactive DNA probes. 
Hybridization of radiolabeled DNA probes to RNA membranes was almost 
identical to Southern blot hybridization. The DNA probe was made with 100 ng of 
template DNA rather than 50 ng, and after addition of 1X TE and EDTA, 
radiolabeled probes were centrifuged through G-50 Sephadex columns 
(Boehringer-Mannheim) to remove unincorporated nucleotides. After 
centrifugation, the DNA probe was boiled five to ten minutes, iced five to ten 
minutes, then added to 5-10 ml of pre-hybridization solution. RNA pre-
hybridization solution consisted of 6X SSPE, 2X Denhardt's reagent, 0.1 % SOS, 
and 100 µg/ml denatured, sheared salmon sperm DNA. The remainder of the 
hybridization procedure was identical. 
Dot blot hybridization 
RNA was applied directly to nylon membranes using a dot blotting apparatus. 
The holes in the apparatus were 3-4 mm in diameter. An RNA sample (or a DNA 
control) was diluted to 15 µI, and 30 µI formamide, 12 µI 37% formaldehyde, and 3 
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µI 20X SSC were added. The RNA was denatured at 68°C for 15 minutes and 
incubated on ice for 5 minutes. Then, 120 µI of 20X SSC were added, and 
samples were kept on ice until added to the dot blot apparatus. A Hybond-N nylon 
membrane pre-wet with 1 OX SSC was placed in the dot blot apparatus and 
samples were added into the wells of the apparatus. Samples were drawn onto 
the membranes by applying a vacuum to the apparatus, and wells were washed 
three times with 1 OX SSC. The vacuum was allowed to dry the membrane for 5 
minutes, then the apparatus was disassembled and the membrane allowed to air 
dry. The nucleic acid on the membrane was crosslinked for 5 minutes on a UV 
lamp. Membranes were hybridized with radioactive DNA probes as with Northern 
blot hybridization. 
Western blot hybridization 
Protein from cultured cells was sometimes analyzed by Western blotting. Media 
was removed from cells, and cells were incubated several minutes in STV or PBS 
containing 5 mM EDTA until cells came loose from the culture flask. The cell 
suspension was centrifuged for 2 minutes at 14,000 rpm, and the supernatant 
removed. The cell pellet was dissolved in 2X Western sample buffert, and the 
solution was pipetted repeatedly to break up the viscous chromosomal DNA. 
Dissolved cell pellets were stored at -20°C until they were used. 
When all samples were ready, a 12% polyacrylamide/SDS running gel was 
made by making a solution of 375 mM Tris-HCI, pH 8.8, 0.1 % SOS, and 12% 
acrylamide/bis. The solution was degassed under vacuum with stirring for 15 
minutes, and 5 x 10-3 parts 10% APS and 5 x 104 parts TE MED were added. The 
acrylamide solution was poured between two glass plates, overlaid with a ribbon of 
water, and allowed to polymerize. The running gel was overlaid with a 4% 
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polyacrylamide/SDS stacking gel. A solution of 125 mM Tris-HCI, pH 6.8, 0.1 % 
SOS, and 4% acrylamide/bis was degassed under vacuum with stirring for 15 
minutes, and 5 x 10-3 parts of 10% APS and 1 x 10-3 parts TE MED were added. The 
4% acrylamide solution was overlaid on the 12% gel, a well comb was added, and 
the 4% gel was allowed to polymerize. The gel apparatus was placed in Western 
running buffert. Samples were heated to 95°C for 10 minutes and loaded into the 
wells of the polyacrylamide gel. Gels were electrophoresed at 200 volts for 45 
minutes. 
After electrophoresis, gels were removed from the apparatus and soaked for 15 
minutes in Western transfer buffert with shaking. A PVDF membrane was prepared 
by soaking 30 seconds in 100% methanol, then 1 O minutes in Western transfer 
buffer. Proteins were electrophoresed from each polyacrylamide gel onto a PVDF 
membrane at 100 volts for one-and-a-half to two hours with a cooling bar. Gels 
were stained with 0.1 % Coomassie Brilliant Blue R250 in 40% methanol and 10% 
acetic acid overnight to verify that proteins ran normally during the first 
electrophoresis. PVDF membranes were washed three times for 5 minutes in 
TTBSt, and soaked overnight with 5% dehydrated milk in TTBS. 
Membranes were washed three times for five minutes in TTBS, incubated for 
one to two hours in the primary antibody, and again washed three times in TTBS 
for five minutes. The PVDF membranes were then incubated in a TTBS solution 
containing 60 nCi/ml 1251-labeled Protein G (8-12 mCi/mg) for one to two hours, then 
washed three times for five minutes in TTBS, and exposed Kodak X-Omat X-ray 
film for various lengths of time to generate autoradiographs of the protein. 
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RESULTS 
Identification of Potential Target Cells 
Our first step in developing a CTL assay was choice of a target cell. Three basic 
qualities necessary in a target cell for a bovine CTL assay using retroviral gene 
delivery are the ability to isolate the cell without killing the animal, a relatively high 
level of class I MHC expression, and susceptibility to retroviral gene delivery. We 
examined primary cell cultures from a variety of tissues in cattle. The class I MHC 
expression and susceptibility to retroviral gene delivery was compared among 
different cultures. An adherent cell culture derived from peripheral blood (PBAC) 
exhibited the best combination of these two characteristics, and were further 
characterized to give an indication of their origin. 
Characterization of primary cells 
A number of different primary bovine cell cultures were isolated by Lawrence 
Elsken's lab at NVSL, Janice Miller's lab at NADC, and by our lab, and these cell 
cultures were chosen as candidate cells for use in a CTL assay. Initially, cells were 
examined for morphology and growth rate (Table 1 ). Primary cell cultures are 
usually a mixture of different cell types, but the cell morphologies that 
predominated in each culture were compared with the morphologies of known cell 
types. When confluent cell cultures are viewed by phase microscopy, a 
cobblestone pattern is indicative of an epithelial or endothelial origin, whereas 
bipolar arrays of cells which appear to form whorls when viewed with the naked 
eye are typical of fibroblasts (29). The BOTONG, BOTUR, BOSK, and FBL had a 
clear fibroblastic morphology. They formed tightly packed bipolar arrays when 
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Table 1. Primary cell cultures 
Cell name Tissue source Morphology/ Likely cell type 
Growth Rate 
BOSK Fetal bovine skin Bipolar arrays, fibroblast 
macroscopic whorls 
High growth rate 
BOTONG Fetal bovine tongue Bipolar arrays, fibroblast 
macroscopic whorls 
High growth rate 
BOTUR Fetal bovine turbinate Bipolar arrays, fibroblast 
macroscopic whorls 
High growth rate 
FBL Fetal bovine lung (outer Bipolar arrays, fibroblast 
membrane) macroscopic whorls 
High growth rate 
BO TEST Fetal bovine testicle Bipolar arrays, some fibroblast, epithelial, 
large and irregular endothelial 
High growth rate 
EBKp Embryonic bovine kidney Cobblestone epithelial, 
Low growth rate endothelial 
PBAC 79A Bovine peripheral blood Large and irregular, epithelial, 
adherent cell some cobblestone endothelial 
Low growth rate 
PBAC 79B Bovine peripheral blood Cobblestone epithelial, 
adherent cell Moderate growth rate endothelial 
PBAC 342 Bovine peripheral blood Bipolar arrays or fibroblast, epithelial, 
adherent cell cobblestone endothelial 
High growth rate 
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viewed under phase microscopy, and the whorls formed by cultured fibroblasts 
were visible to the naked eye. BOTONG, BOTUR, BOSK, and FBL cells all divided 
quickly in culture. EBKp did not often grow into tightly packed cell cultures, but 
usually left space between cells at confluence. Where cell-cell contact occurred, 
EBKp formed cobblestone patterns, indicating an epithelial or endothelial origin. 
EBKp were very regular in size and were round with a centered nucleus, much like 
a fried egg, and grew more slowly in culture. BOTEST cells had a more 
heterologous morphology and formed both bipolar arrays and arrays of a loose 
cobblestone pattern with very large irregularly shaped cells interspersed in the 
culture. Whorls were not visible in BOTEST cultures, and so they somewhat 
resembled fibroblasts and epithelial and endothelial cells. PBAC 798 cells had a 
cobblestone appearance at confluence and divided quickly, thus appearing to be 
epithelial or endothelial. PBAC 79A were much larger cells which did not pack 
tightly at confluence, were rather irregularly shaped, and divided more slowly. 
They occasionally formed cobblestone arrays at confluence, and tentatively 
appeared to be epithelial or endothelial. PBAC 342 divided quickly and formed 
both cobblestone and bipolar arrays at confluence, but no macroscopic whorls 
were visible, so PBAC 342 could also have been fibroblasts, epithelial or 
endothelial cells. 
Morphologies give only a partial indication of cell type, whereas biochemical 
indicators can provide much more certainty in cell type determinations. To better 
determine cell type, the different cell cultures were tested for expression of the 
intermediate filaments, vimentin and cytokeratin. Vimentin has been shown to be 
present in cells of mesenchymal origin such as fibroblasts, macrophages, and 
endothelial cells (22,28,42,65), whereas cytokeratin has been shown to be 
confined to epithelial cells (27,42,80). MDBK are a bovine epithelial cell line, and 
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HeLa are a human epithelial line. Both cell lines should contain cytokeratin but not 
vimentin. EJG and CPAE on the other hand are bovine endothelial cells, and 
should contain vimentin but not cytokeratin. ICC was performed for each 
intermediate filament, then the number of stained and unstained cells were 
counted out of at least 500 cells, and the percent positive was calculated. The 
results are summarized in Table 2. 
Table 2. C ttokeratin and vimentin staining 
Percentage of Cells 
Stained Positive 
Cell name Cell type Cytokeratin Vimentin Deduced cell type 
He La epithelial 40 100 N/Aa 
MDBK epithelial 2 100 N/A 
EJG endothelial 0 100 N/A 
CPAE endothelial 0 100 N/A 
BO MAC macrophage 100 100 N/A 
BOSK primary 0 100 fibroblast 
BOTONG primary 0 100 fibroblast 
BOTUR primary 0 100 fibroblast 
FBL primary 0 100 fibroblast 
BO TEST primary 2 100 epithelial 
EBKp primary 1 100 epithelial 
PBAC 79A primary 0 100 unknown 
PBAC 798 primary 0 100 unknown 
PBAC 342 primary 0 100 unknown 
aN/ A = not applicable 
Surprisingly, every cell line stained positive for vimentin, including the non-
mesenchymal MDBK and HeLa cells. The studies which found vimentin only in 
mesenchymal cells were performed mostly with in situ staining of tissue samples, 
so it is possible that expression of vimentin was gained by in vitro culture of the 
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epithelial cells. In any case, vimentin's presence in all of the primary cell cultures 
was not highly meaningful. Of the primary cell cultures, only BOTEST and EBKp 
reacted with the cytokeratin antibody. The percent of cells positive for cytokeratin 
was low, but comparable to that found in the bovine epithelial cell line, MDBK. 
Thus, BOTEST and EBKp cultures contained epithelial cells. The lack of 
cytokeratin in the BOTONG, BOTUR, BOSK, and FBL cultures supported the 
morphologic evidence that they contained predominantly fibroblasts. The lack of 
cytokeratin staining ruled out the presence of epithelial cells in the PBAC cultures. 
The PBAC were isolated from blood collected by venipuncture, and since they all 
formed cobblestone arrays to some degree, an endothelial origin seemed likely, 
but not enough information was available to make that conclusion with much 
certainty. 
Class I MHC expression 
The different cell cultures were analyzed by FAGS analysis for their relative 
levels of class I MHC expression. A typical histogram set generated by FAGS 
analysis of class I MHC expression is shown in Figure 2. Expression of class I 
MHC was demonstrated by the shift of the shaded histogram (MHC-labeled cells) 
to the right of the unshaded one (unlabeled cells), and for the histogram set shown 
in Figure 2, both EBKp and PBAC 79A expressed class I MHC. The relative level of 
MHC fluorescence of each group of cells was calculated by subtracting the mean 
fluorescence of the unlabeled cells from the mean fluorescence of the labeled cells 
(Figure 3). Although the two sets of data yielded slightly different absolute numbers 
for most of the cell cultures, the relative relationships between the different cell 
cultures remained largely identical. 
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Figure 2. FACS histograms of class I MHC expression. Cells were labeled with 
an anti-class I MHC antibody and a secondary fluorescent antibody 
(shaded histogram) or the secondary antibody alone (unshaded 
histogram). 
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Figure 3. Level of class I MHC expression. Class I MHC expression was 
calculated as the mean fluorescence of cells analyzed by FAGS 
analysis with an antibody to class I MHC minus the mean fluorescence 
of cells labeled with the secondary antibody only. Two FACS analyses 
of all cells were performed, and the data for each analysis is shown in a 
different shade of gray. 
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Of the primary cell cultures, 80SK, 80TONG, 80TUR, F8L all had a relatively 
low level of class I MHC expression. These cell all bore a strong morphological 
resemblance to fibroblasts, and this data is consistent with previous work showing 
that bovine fibroblasts have a rather low level of class I MHC and do not function 
well as a CTL target cells ( 14). The E8Kp also had a relatively low level of class I 
MHC expression, whereas the 80TEST had a high level. Thus the presence of 
epithelial cells in a cell culture did not necessarily correlate with higher or lower 
levels of class I MHC expression. 
The level of class I MHC expression varied widely among the P8AC isolates. 
P8AC 79A expressed class I MHC far higher than any other cell type tested in this 
study; P8AC 798 had the second highest level of expression, though it did not 
exceed the other cell cultures by such a large amount; and P8AC 342 had one of 
the lowest relative levels seen in this study. Therefore, the differences seen in 
morphology and growth rate of the P8AC cultures extended to the biochemical 
level and indicated that they may not have been the same cell type. The higher 
levels of expression seen in 80TEST, P8AC 79A, and P8AC 798 made them the 
promising candidates as CTL target cells, based simply on class I MHC expression. 
Susceptibility to retroviral gene delivery 
For cells to function in a CTL assay using retroviral gene delivery, they need to 
be highly susceptible to infection by the retroviral vectors. So in addition to 
examining class I MHC expression, potential target cells were evaluated for their 
susceptibility to retroviral gene delivery (Figure 4). All cells were susceptible to 
infection with retroviral vectors produced by PG13 vector-producer cells, in 
accordance with previous results for bovine cells (56) , but infection titers varied by 
several orders of magnitude. Cells with titers between 103 and 104 would be 
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Figure 4. Susceptibility to retroviral gene delivery. Gene delivery was measured 
in duplicate as the number of neomycin-resistant colonies after infection 
with 10-fold serial dilutions of PG 13/LNc8 retroviral vector. Numbers 
shown are the average of duplicate experiments. Individual titers varied 
by less than 0.5 logs from the mean in all cells. 
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minimally suitable as target cells with a 1 to 1 a% infection rate, and cells with titers 
higher than 1 a4 would be much more suitable with infection rates above 1 a%. 
Titers below 1 a3 indicated that cells would be very unsuitable for a CTL assay 
using retroviral gene delivery. 
All the fibroblastic cells, BOSK, BOTONG, BOTUR, and FBL, had titers well 
above 1 a4 , with BOSK and BOTUR showing titers of approximately 1 as, indicating 
that nearly 1 aa% of the cells were being infected. The titer of slightly above 1 as in 
BOTUR is probably because these cells divide very quickly and grew to more than 
1 as cells per well in the first few hours of the infection. The EBKp had a titer below 
1 a3, whereas the BO TEST showed a titer of above 1 a4·s, again demonstrating that 
although both cultures contained epithelial cells, their suitability as target cells was 
very different. 
The susceptibility of the PBAC isolates also varied immensely. With a titer of 
about 1 a3·2, only about 15% of PBAC 79A cells were infected by the retroviral 
vector. The PBAC 798 and PBAC 342 both were highly susceptible to infection 
with titers above 1 a4·s. Interestingly, the susceptibility to retroviral gene delivery 
correlated with the speed at which the cell cultures grew (Table 1 ), which is 
reasonable since simple retroviruses only infect dividing cells. The correlation is 
useful because it implies that growth rate can provide a method for approximating 
the titer which can be expected from different cell isolates. 
PBAC are most suitable 
To be useful as target cells, isolates need to have both high class I MHC and 
high susceptibility to retroviral gene delivery. Examining both criteria 
simultaneously (Figure 5) gave an indication of the target cell potential of each of 
the primary cell cultures. EBKp cells had a low level of class I MHC expression and 
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Figure 5. Target cell potential. This figure contains data from both Figure 3 and 
Figure 4. The name of each cell type is placed on the graph at its 
corresponding position for class I MHC expression and gene deliviery 
titer. P342 refers to PBAC 342 cells. The shaded region highlights the 
cells with the high combination of class I MHC expression and 
susceptibility to retroviral gene delivery. The highlighted cells are those 
most suitable as CTL target cells. 
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a low gene delivery titer and would be quite unsuitable as CTL target cells. 
Though P8AC 79A expressed a high level of class I MHC, they were not very 
susceptible to retroviral gene delivery, and thus would not make very good CTL 
target cells. Conversely, 80SK, 80TONG, 80TUR, F8L, and P8AC 342 all had 
high gene delivery titers, but low class I MHC expression; they would also make 
poor CTL target cells. Peripheral blood isolate 798 (P8AC 798) and bovine testes 
cells (80TEST) had the highest combination of class I MHC expression and gene 
delivery titer, and they would thus be most useful as potential target cells in a CTL 
assay using retroviral gene delivery. 
We chose to pursue further study with the P8AC cells rather than the 80TEST 
cells for several reasons. Isolation of P8AC requires far less surgical manipulation 
of the animal donor than do testes cell isolations, a CTL assay using testes cells 
would restrict researchers to studies of male cattle, and previous results indicate 
that bovine testes cells do not function well as target cells ( 14). 
PBAC cell type characterization 
Different PBAC isolates demonstrated noticeable differences in morphology, 
growth rates, susceptibility to retroviral gene delivery, and class I MHC expression 
(Tables 1 and 2, Figures 3 through 5). The cells were isolated as overgrowths of 
P8MC cultures, and there was some uncertainty about their origin. So, further 
characterizations were performed on the different PBAC isolates to try to provide 
guidelines as to which PBAC phenotype correlated with high potential as CTL 
target cells. 
None of the PBAC isolates contained epithelial cells, as evidenced by the 
absence of cytokeratin. They were isolated by collecting peripheral blood 
mononuclear cells (PBMC) as buffy coats from peripheral blood and selecting for 
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adherent cells. Because buffy coats contain primarily white blood cells, all PBAC 
isolates were tested for expression of CD45, a leukocyte marker. Fresh PBMC had 
very bright staining for CD45 on their surface by IFA, but PBAC showed no staining 
(data not shown). Thus, PBAC were not leukocytes. 
Typical endothelial cell morphology is a cobblestone appearance at 
confluence. Some of the PBAC exhibited cobblestone morphology (Table 1 ), so 
we tested the cells for two biochemical characteristics of endothelial cells: 
expression of von Willebrand factor and uptake of Dil-Ac-LDL. Von Willebrand 
factor is produced exclusively by vascular endothelium. Ac-LDL is taken up via the 
"scavenger cell pathway" present in macrophages and most vascular endothelial 
cells (45,85). When cells take up the fluorescently tagged form of Ac-LDL, known 
as Dil-Ac-LDL, the fluorescent Oil tag accumulates in cytoplasmic deposits, causing 
a punctate fluorescence when viewed under the microscope. Bovine pulmonary 
artery endothelial cells (CPAE) stained strongly positive for von Willebrand factor 
by IFA (data not shown), but all PBAC isolates were negative (data not shown), and 
thus were not vascular endothelial cells. PBAC were incubated with Dil-Ac-LDL 
and their fluorescence measured by FACS analysis. Though all PBAC isolates 
took up far less Dil-Ac-LDL than CPAE positive control cells, their levels of uptake 
differed (Figure 6). PBAC 79B cells took up significantly more Dil-Ac-LDL than the 
MDBK epithelial cell control or the NIH/3T3 fibroblast control. PBAC 79A and 342 
took up more than NIH/3T3 cells, but less than MDBK. Thus, whereas as the 
vascular endothelial cell control, CPAE, had a high level of Dil-Ac-LDL uptake, 
PBAC 79B had a moderate level of uptake, and PBAC 79A and 342 had low levels 
of uptake. 
The absence of von Willebrand factor and moderate level of Dil-Ac-LDL uptake 
shown by PBAC 79B were consistent with the cell characteristics reported for 
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Figure 6. Dil-Ac-LDL uptake. Cells were incubated with normal media containing 
5 µg/ml Dil-Ac-LDL, and uptake of the fluorescent compound was 
measured by FACS analysis. Values shown are the average of 
triplicate measurements, and error bars indicate standard deviation. 
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cultured high endothelial cells (45,71 ). High endothelial cells are involved in 
lymphocyte trafficking in vivo, and freshly isolated lymphocytes bind high 
endothelial cells in vitro (45,71). To test whether the PBAC isolates were high 
endothelial cells, a lymphocyte binding assay was performed, and the number of 
lymphocytes bound per cell was calculated (Figure 7). Again, differences were 
observed among the various PBAC isolates. The level of lymphocyte binding in 
PBAC 79A and 798 was consistent with reported results for high endothelial cells, 
but in PBAC 342 lymphocyte binding was at a level much lower than that found in 
high endothelial cells. 
Based on their cobblestone morphology, lack of von Willebrand factor, 
moderate level of Dil-Ac-LDL uptake, and level of lymphocyte binding, PBAC 798 
appear to be high endothelial cells. PBAC 79A was isolated from the same sample 
of blood as 798, and they differed from PBAC 798 mostly in their growth rate and 
level of Dil-Ac-LDL uptake. In vitro, vascular endothelial cells can lose the 
scavenging cell pathway, and their levels of Dil-Ac-LDL uptake will fall. PBAC 79A 
were probably high endothelial cells, but in course of being grown in culture their 
growth rate may have slowed and they may have lost their ability to take up 
moderate levels of Dil-Ac-LDL. PBAC 342, on the other hand, did not bind 
lymphocytes efficiently, they sometimes had a fibroblastic bipolar morphology 
(Table 1 ), and their target cell potential closely resembled that of the other 
fibroblastic primary cells (Figure 5). The most likely explanation is that the PBAC 
342 culture contained mostly fibroblasts. The appearance of sectors of 
cobblestone morphology may have been due to high endothelial cells which were 
later overgrown by fibroblasts. 
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Figure 7. Lymphocyte binding assay. Adherent cells were co-cultured with fresh 
lymphocytes (PBMC) for 2 hours, non-adherent cells were washed off, 
and cells were fixed and stained with CD45. The number of 
lymphocytes per adherent cultured cells was counted, and the ratio is 
given in the graph. The ratio of lymphocytes which bound high 
endothelial cells has been previously determined (45), and it is 
displayed with the reported standard error. 
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Summary 
PBAC 798 cells were the isolate most suitable as a CTL target cell, as 
determined by high class I MHC expression and a high susceptibility to retroviral 
gene delivery. They appeared to be high endothelial cells, based on a 
cobblestone morphology, a lack of von Willebrand factor expression, a moderate 
level of Dil-Ac-LDL uptake, and a lymphocyte binding greater than 0.4 lymphocytes 
per cell. High endothelial cells are normally found in lymph nodes, but they have 
been previously isolated from bovine peripheral blood adherent cultures (71 ), just 
as the PBAC were. The less suitable PBAC 79A isolate also probably contained 
high endothelial cells, but its slow growth rate made it less susceptible to gene 
delivery, and thus less suitable as a CTL target cell. PBAC 342 cells did not 
appear to be high endothelial cells and had a low level of class I MHC expression, 
making them very unsuitable as CTL target cells. In conclusion, high endothelial 
cells isolated from peripheral blood are the most promising candidates for target 
cells in a CTL assay which uses retroviral gene delivery. 
Production of Retroviral Vectors for Delivery of Bovine Genes 
With a target cell chosen, the next step in developing a CTL assay was 
production of a retroviral vector which could deliver genes cloned from a bovine 
virus into the target cells. The model bovine virus used in this study was BIV. 
Production of the retroviral vector involved construction of transfer vector plasmids 
carrying BIV genes, transfection of packaging cells with the plasmids to make 
vector producer cells, and collection of retroviral vectors from the supernatant of 
vector producer cells. Target cells were then infected with the recombinant 
retroviral vector and tested for expression of the BIV genes. 
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BIV CA gene delivery and protein production 
The CA subunit of the BIV gag gene was chosen to be used in transfer vector 
construction (Figure 8) and gene delivery to target cells for several reasons. 
Monoclonal and polyclonal antibodies reactive to the CA protein were available. 
BIV-infected cattle develop humoral immune responses to the CA protein (4), and 
CTL specific to the FIV CA protein have been detected in FIV-infected cats by a 
CTL assay which used retroviral gene delivery (78). 
LNCX/CA construction and packaging cell assembly. The LNCX/CA 
transfer vector was made by first PCR amplifying the BIV CA gene from the 
pBacHisC/gag3 plasmid with primers carrying restriction enzyme sites and then 
ligating the PCR product into the easily manipulated intermediate plasmid, pCRll. 
The pBacHisC/gag3 plasmid was used as a source because it had previously been 
used to produce a baculovirus-gag3 fusion protein which could be detected by 
Western blot hybridization with the CA-specific monoclonal antibody, indicating a 
preservation of the open reading frame and the sequence of the monoclonal 
binding site in the CA gene. Intermediate plasmids containing the correct insert 
were detected using colony blot hybridization. Bacterial colonies carrying the CA 
gene were grown in quantity, and the pCRll/CA plasmid was isolated. Plasmids 
were screened by restriction enzyme digestion and fragment sizes visualized by 
agarose gel electrophoresis. Intermediate plasmids with the expected banding 
pattern were sequenced to verify that the BIV gene was intact. The BIV gene was 
then subcloned into the pLXSN transfer vector using the restriction enzyme sites 
added by the PCR primers. Correct construction of the transfer vector was also 
verified using colony blot hybridization, restriction enzyme analysis, and DNA 
sequencing. 
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Figure 8. LNCX/CA transfer vector construction. The BIV CA gene segment was 
amplified from the baculovirus expression plasmid, pBacHisC/gag3, 
which has been shown to produce BIV CA protein detectable by 
monoclonal antibody (data not shown), and ligated in the pCRll plasmid. 
After correct amplification and ligation were verified, the CA gene 
fragments was excised from the intermediate plasmid by restriction 
enzyme digestion and ligated into LNCX. 
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Packaging cell transfection, gene delivery, and testing of 
expression. The LNCX/CA plasmid was used to transfect PG 13 packaging cells, 
and stable transfectants were selected for neomycin resistance (neoR) with G418. 
NeoR colonies formed, confirming successful transfection of packaging cells. 
Supernatant from neoR PG 13--LNCX/CA cells presumably contained recombinant 
CA retroviral vector, and the supernatant was used to infect bovine FBL cells. 
Upon selection with G418, neoR colonies formed. These results confirmed both 
production of retroviral vector and delivery of vector-borne genes into bovine cells. 
In order to verify that the BIV CA protein was being produced, neoR cells were fixed 
with methanol and stained by ICC using a CA-specific monoclonal antibody. 
Neither PG13--LNCX/CA cells nor the neoR FBL cells visibly reacted with the 
antibody, suggesting that no CA protein was being produced after transfection or 
gene delivery. The absence of detectable protein could have been the result of 
any of several complications. In packaging cell lines, transfer vectors can undergo 
recombination to delete the inserted gene, in this case the CA gene. The promoter 
controlling the inserted gene can also become silenced. Both events block protein 
production from the inserted gene. When protein expression is blocked in a 
majority of cells, one way to find the unblocked minority is to examine clonal 
populations of cells. 
Clonal isolation of packaging cells and testing of expression. Clonal 
populations are the result of a single integration of the transfer vector in the host 
cell chromosome. Cells with an integration site that has a high probability of 
recombination or gene silencing will lose protein production within the first few 
rounds of cell division, and the entire colony will be negative. Cells with a more 
stable integration event will produce colonies with at least a portion of positive 
cells. By examining clonally-derived colonies, positive cells are concentrated 
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together and more easily identified as being above background than they would be 
when mixed together in a pool of cells. PG 13--LNCX/CA cells were taken from the 
pool of cells generated by the first transfection, seeded at limiting dilutions, allowed 
to form colonies, and tested for CA protein by ICC. Several hundred colonies were 
examined, but all were negative for protein. 
It was possible that the packaging cells which had eliminated expression of the 
CA protein gained a selective advantage over those which maintained expression. 
The non-expressors could have outdivided the cells expressing the CA protein, 
eliminating the expressors before the cells were divided into clonal populations. 
To remove the bias that may have been produced by growing cells in a pool, 
another round of transfection and selection of PG13 and PA317 cells (a similar 
packaging line) was performed and colonies were grown up at limiting dilutions 
during the initial neomycin selection. Cell colonies were tested by ICC, but again 
all populations were negative for protein. 
Alternative transfer vectors 
It was not possible to detect protein produced by the LNCX/CA vector after 
transfection into packaging cells, gene delivery in bovine cells, or clonal selection 
of transfected packaging cells. One likely explanation was that the LNCX/CA 
vector had been somehow improperly constructed. For example, in constructing 
the vector, artificial start and stop codons had been introduced in the CA gene 
during PCR amplification. At that time, no consideration was given to the 
translation initiation context of the artificially introduced start codon, and the non-
consensus initiation context may have led to a large reduction in the level at which 
transfer vector RNA was transcribed. Other unknown construction errors may also 
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have taken place, and for this reason several other transfer vectors were 
constructed. 
LNCX constructs. Several other LNCX transfer vectors were made using the 
different segments of the BIV genome (Figures 9 and 10). The gag3 portion of BIV 
was used because it is exactly the same part of gag which was originally used in a 
fusion protein to detect anti-Gag humoral immune responses (4), and so has been 
shown to react with Gag-specific polyclonal and monoclonal antibodies. The entire 
gag gene was used to construct LNCX/gag because it contains the natural 
translation initiation and termination sites, so mRNA containing it should be as 
efficiently translated as mRNA from wild-type BIV virus. As shown in Figure 9, the 
plasmid p61-3E which was used as the source for gag in LNCX/gag had also been 
used as the source of gag3 in p8acHisC/gag3, and thus the source gene should be 
able to react with the available Gag-specific antibodies. BIV-infected cattle develop 
antibodies to the protein product of a portion of the env gene, known as Env8 (19), 
so sera from these cattle can be used to detect Env8. The Env8-specific antibodies 
were detected using an E. coli TrpE-Env8 fusion protein produced by the 
pTrpE/env8 plasmid, so this plasmid was used as the source of the env8 in 
LNCX/env8. Construction of the alternative LNCX transfer vectors was performed 
similarly to construction of LNCX/CA. 
Direct transfection, which has been reported to increase the frequency of 
transfer vector rearrangement and recombination (57), was used to introduce 
LNCX/CA transfer vector into PG13 packaging cells. Rather than being directly 
transfected into PG13 cells, the LNCX/gag3, LNCX/gag, and LNCX/env8 transfer 
vectors were instead transiently transfected into the PA317 packaging cell line, and 
recombinant retroviral vectors in the supernatant from the PA317 were used to 
infect PG 13 packaging cells. This technique reportedly results in a much higher 
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Figure 9. BIV genes used in transfer vector construction. A. Map of the provirus genomic organization of BIV. 8. 
DNA segments which were amplified for cloning into transfer vectors, aligned with the location in the BIV 
provirus from which they are taken. 
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Figure 10. LNCX transfer vector construction. Several different-sized segments of the BIV gag gene and one 
segment of the BIV env gene were used to construct transfer vectors in a manner similar to LNCX/CA 
construction. The gag3 insert was amplified from pBacHisC/gag3, and the gag insert was amplified from 
p61-3E, a pUC19 plasmid containing the 5' half of the BIV genome which had been used to construct the 
pBacHisC/gag3 plasmid. The envB insert was taken from the pATH/env8 plasmid which produces an E. 
coli TrpE-env8 fusion protein that reacts with sera from BIV-infected cattle (19). BIV DNA fragments were 
PCR amplified from the plasmids listed in the top row and ligated in intermediate plasmids. When correct 
amplification was verified, BIV gene fragments were subcloned into LNCX. 
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proportion of unrearranged transfer vector integrated in the packaging cells' nuclei 
(57). Serial dilutions of infected PG13 packaging cells were passed and selected 
for neomycin resistance. ICC was performed on the colonies using a Gag-specific 
monoclonal antibody for neoR PG13 cells with the LNCX/gag3 or LNCX gag, and 
using a polyclonal calf serum previously demonstrated to react with Env8 protein 
(4) for cells with LNCX/env8. No reaction was seen with any of the colonies 
containing LNCX/gag3 or LNCX/gag. Small differences in antibody reactivity were 
seen among colonies containing the LNCX/env8 vector, however the level of 
background staining of uninfected PG13 control cells with the Env8-specific 
polyclonal sera was much higher than with the monoclonal, and sera did not react 
with any colonies to a greater degree than with the uninfected controls. No protein 
expression was detected in clonal populations of PG 13 packaging cells with 
LNCX/gag3, LNCX/gag, or LNCX/env8. Because of the different sources of the BIV 
genes and the different steps necessary in the construction of these vectors, it did 
not appear that the lack of expression was merely a result of faulty plasmid 
construction. 
LXSN constructs. Another possible explanation for the lack of expression is 
some unknown inactivating interaction between the BIV lentiviral genes and the 
retroviral elements in the LNCX plasmid and the packaging cell. There is 
anecdotal evidence that lentiviral genes are spliced out of LNCX in cells (35,73). 
The LXSN transfer vector has been successfully used to express the CA protein of 
feline immunodeficiency virus (FIV), another of the lentiviruses (78). The pLXSN 
plasmid was used to construct the LXSN/gag and LXSN/gag3 transfer vector 
plasmids (Figure 11 ). In order to eliminate any interaction between the retroviral 
genes in the packaging cell and the transfer vector, plasmids were transiently 
transfected into 293 cells, an easily transfected human kidney cell line. After two 
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Figure 11. LXSN transfer vector construction. As with the LNCX vectors, BIV DNA 
segments were amplified from source plasmids, ligated in intermediate 
plasmids, and subcloned from the intermediate plasmid into LXSN. 
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days, 293 cells with each transfer vector were tested for protein by ICC using either 
methanol or formaldehyde fixation and either the CA-specific monoclonal antibody 
or a Gag-specific rabbit polyclonal. No specific protein expression was seen in 
cells with either LXSN/gag or LXSN/gag3 using any combination of fixative and 
antibody. The lack of expression seen with the LNCX-based transfer vectors was 
not due solely to an interaction of the BIV lentiviral genes with the retroviral genes 
in the LNCX plasmid or the PG13 packaging cells. 
· Eukaryotic expression constructs. A possible reason that no protein was 
detected is that the sequence of the BIV genes may have been faulty. This 
possibility seemed unlikely since sequencing of the DNA revealed no stop codons 
or frameshifts. The amino acid sequence appeared to contain two amino acid 
changes from the previously reported BIV sequence, but these were present in the 
pBacHisC/gag3 source plasmid as well, and protein produced by that plasmid 
reacted with the CA-specific monoclonal antibody. 
We did not have a gag-containing plasmid that we could transfect into PG 13 or 
293 cells to use as a positive control for ICC. Therefore, the problem may not have 
been a lack of expression, but instead merely a lack of detection. For this reason, 
we constructed gag and gag3 eukaryotic expression plasmids. The intermediate 
plasmid used in construction of the LXSN transfer vectors was pCR3.1 , a 
eukaryotic expression vector which uses the CMV promoter (Figure 11 ), and the 
pCR3.1 /gag3 and pCR3.1 /gag were tested for Gag expression. One plasmid clone 
of pCR3.1/gag3 and twenty different plasmid clones of pCR3.1/gag were 
transfected into 293 cells. Four sets of 293 cells transfected with different 
pCR3.1/gag plasmid clones were selected for neomycin resistance for three weeks 
before they were tested for Gag protein, and the remainder of transfected 293 cells 
were tested for protein two days after transfection. No cells tested positive by ICC 
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using any combination of methanol or formaldehyde fixation and CA-specific 
monoclonal or Gag-specific rabbit polyclonal antibody. These results indicated that 
either some problem had arisen in the nucleotide sequences of the segments of 
the gag genes that we used, or detection of Gag by ICC, though adequate to detect 
cells infected with wild-type BIV virus, was not sufficient to detect Gag protein 
produced by plasmids. 
Western blotting. Since Gag protein was not detectable by ICC, Western blot 
hybridization was used as an alternative method to try to detect Gag protein in 
transfected cells. Lysates were collected from 293 cells transiently transfected with 
the LNCX/CA, LNCX/gag3, LNCX/gag, LXSN/gag3, LXSN/gag, or pCR3.1/gag3 
plasmids. Cell lysates were also taken from the sixteen sets of 293 cells transiently 
transfected with different pCR3.1/gag plasmid clones and the four sets of neoR 293 
cells stably transfected with pCR3.1 /gag plasmid clones. The lysates were 
analyzed by Western blot using a CA-specific monoclonal antibody (Figure 12). 
Purified BIV virus was used as a positive control. A strong reaction was detected to 
the 26 kDa CA protein in BIV-infected cells, but no other proteins were detected. 
Although protein was detectable in virus isolated from BIV-infected cells, the CA 
protein is the most prevalent component of virions, so by concentrating the virus, 
the CA protein was concentrated as well. The lack of protein in cells transfected 
with the different gag plasmids could have been due to a non-functional form of the 
gag gene in the plasmids, but this seems unlikely since Gag protein was readily 
detectable by both ICC and Western blot in insect cells transfected with the 
pBacHisC/gag3 plasmid. An alternate possibility is that the Gag-specific antibodies 
were not sensitive enough to detect the amount of Gag protein produced in cell 
transfected with the LNCX, LXSN, or pCR3.1 plasmids. 
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Figure 12. Western blots of cells transfected with transfer vectors. Lanes 1 and 27 contain protein purified from BIV-
infected cells. Lane 2 contains the lysate of untransfected 293 cells. Lanes 3-13, 15-22, and 26 contain 
the lysates of 293 cells transiently transfected with different gag-containing plasmids as follows: 3 with 
LNCX/CA, 4-5 with LNCX/gag3, 6 with LNCX/gag, 7-8 with pCR3.1/gag, 10 with LXSN/gag, 11 with 
LXSN/gag3, and 9, 12-13, 15-22, and 26 with pCR3.1/gag. Lanes 14 and 23-25 contain lysates of 293 
cells transfected with pCR3.1 /gag and selected for neomycin resistance for four weeks with G418. 
Western blotting was performed using a monoclonal antibody to BIV CA and 1251-labeled Protein G. The 
bands indicated by solid arrowheads contain the 26 kDa CA protein from BIV-infected cells. 
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Transcriptional activity 
Production of Gag, CA, or Env8 proteins was not detected from any of transfer 
vector or eukaryotic expression plasmids in any of the experiments outlined thus 
far. The block to protein production could be at a translational level, or at a 
transcriptional level. Total RNA was isolated from a number of cells with transfer 
vectors or pCR3.1 eukaryotic expression vectors, and several tests were performed 
to determine if the transfer vectors and the eukaryotic expression plasmids were 
being transcribed to RNA within the cells. 
RNA isolation. RNA was isolated from PG 13 cells, from PG 13/LNc8 (these 
carry only the neoR gene), and PG13--LNCX/CA. Total RNA was also taken from 
normal FBL cells, FBL cells infected with recombinant LNCX/CA retrovirus, and 
neoR FBL--LNCX/CA cells. RNA was isolated from normal 293 cells and from 293 
cells transiently transfected with pCR3.1/gag3, pCR3.1/gag, LXSN/gag3, or 
LXSN/gag. Total RNA from BIV-infected cells was used as a positive control for 
gag. 
RT-PCR. Total RNA from normal PG13 cells, PG13/LNc8, PG13--LNCX/CA, 
unselected FBL--LNCX/CA, and neoR FBL--LNCX/CA was analyzed by RT-PCR 
(Figure 13). The templates were amplified using primers for neoR, CA, and a 
primer pair outside the multi-cloning site of LNCX, all of which give 0. 70-0. 76 kb 
products. No 0.7 kb bands were present in either normal PG13 (lanes 4-7) or 
normal FBL cells (lanes 8-11) or from reactions without reverse transcriptase (lanes 
2, 4, 8, 12, 19, and 23), as expected. A 0.7 kb CA band amplified from the BIV RNA 
(lane 3). From PG13/LNc8, only the neoR primers amplified a 0.7 kb band (lane 9). 
From PG13--LNCX/CA, FBL--LNCX/CA, and neoR FBL--LNCX/CA, 0.7 kb bands 
amplified in the CA, neoR, and LNCX reactions (lanes 13-16, 20-22, and 24-26). 
These results indicated that in both packaging cells and bovine cells with the 
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Figure 13. Analysis of gene expression by RT-PCR in stably transfected and infected cells. Total RNA from cells with 
the LNCX/CA transfer vector was amplified using primers specific for the CA and neoR genes, or with 
primers outside the LNCX multi-cloning site. Primers are indicated above the gel and RNA templates are 
labeled below. Reactions labeled RT- were run without reverse transcriptase to test for DNA 
contamination. Positive controls included BIV-infected cells and PG13/LNc8 cells. Negative controls 
included normal PG 13 cells and normal FBL cells. PG 13--LNCX/CA cells were stably transfected with 
LNCX/CA plasmid. FBL--LNCX/CA were infected with LNCX/CA retroviral vector and used either 
unselected or selected for neoR. The expected RT-PCR product sizes from the CA, neoR, and LNCX 
primer pairs are indicated. 
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LNCX/CA transfer vector, the CA and neoR RNA was produced. In addition, in the 
LNCX reactions in cells with the transfer vector, a single clear band was present, 
indicating that the CA RNA was not spliced out of RNA transcripts. 
The presence of CA RNA was measured in total RNA from 293 cells transiently 
transfected with either pCR3.1/gag3, pCR3.1/gag, LXSN/gag3, or LXSN/gag 
(Figure 14A). The expected PCR product for the CA primers is 703 base pairs (bp), 
and a 0.7 kb product was detected in BIV-infected controls (panel A, lane 2), as 
well as 293--LXSN/gag3 (lane 6), 293--LXSN/gag (lane 10), and 293--
pCR3.1/gag3 cells (lane 8). The 0.7 kb band was not detected in normal 293 cells 
(lane 4), or in cells to which no reverse transcriptase had been added (lanes 3, 5, 
7, 9, 11, and 13), so the gag gene was not present in 293 cells before transfection, 
and no contaminating gag DNA was present in RT-PCR reactions. The expected 
RT-PCR product was not detected in 293--pCR3.1/gag cells (lane 12), which could 
either indicate that that transfection was not successful, or that something was 
wrong with the plasmid. LXSN/gag, the derivative of pCR3.1/gag, was transcribed, 
so the lack of gag RNA was not due to a lack of the correct gag DNA. A poor 
transfection seems the most likely reason. In any case, the gag gene of 
LXSN/gag3, LXSN/gag, and pCR3.1/gag3 was transcribed by 293 cells, and thus 
the lack of protein was not due to an absence of RNA caused by a problem such as 
promoter-cell incompatibility. 
A further RT-PCR analysis was performed on a total RNA from 293 cells using 
several other primer pairs (Figure 148). An attempt was made to amplify RNA from 
293--pCR3.1/gag and 293--pCR3.1/gag3 cells using a 5' primer from inside the 
gag gene and a 3' primer from outside the pCR3.1 multi-cloning site (panel B, 
lanes 8 and 9). The expected sizes are 1547 bp for pCR3.1/gag and 937 bp for 
pCR3.1/gag3. Neither RT-PCR product was detected. This was not very surprising 
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Figure 14. Analysis of gene expression by RT-PCR in transiently transfected cells. 
Total RNA was isolated from 293 cells transiently transfected with the 
indicated transfer vector. In panel A, RT-PCR was performed with and 
without reverse transcriptase for all six total RNA samples using primers 
specific for BIV CA. The arrowhead indicates the expected position of 
the 703 bp CA RT-PCR product. In panel B, RT-PCR was performed 
with templates indicated by the lower labels using primers indicated by 
the upper labels. The solid arrowhead in panel B indicates the 
expected position of the 746 bp neoR RT-PCR product. 
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for the 293--pCR3.1/gag RNA since no CA RNA had been detected, but for 293--
pCR3.1/gag3 it may be a result of a poor primer pair since no positive control was 
used. A similar amplification of 293--LXSN/gag and 293--LXSN/gag3 was 
performed using primers outside the multi-cloning site of LXSN (panel B, lanes 1 O 
and 11 ). The expected product for LXSN/gag is 1501 bp, and for LXSN/gag3 an 
891 bp product is expected. Neither product was detected, but again no positive 
control was used. It is possible that only the interior of the gene was transcribed, 
but this seems highly unlikely. On the other hand, when RT-PCR was performed on 
293--LXSN/gag RNA using primers for neoR RNA, the expected 7 46 bp product 
was found (panel B, lane 13). This reinforced the conclusion that the LXSN 
transfer vectors were capable of being transcribed in 293 cells. 
Northern blotting. RT-PCR can detect an extremely small amount of RNA, 
and a positive reaction gives no indication of the amount of RNA present, so some 
of the RNA samples were electrophoresed in a denaturing agarose gel and 
analyzed by Northern blot hybridization (Figure 15). A BIV gag probe gave a 
strong signal from total RNA from BIV-infected cells (lane 2). In 293--LXSN/gag 
cells (lane 7), the BIV gag probe detected a 4.3-4.5 kb band, which is the expected 
size of RNA transcribed off the 5' LTR and terminating at the 3' LTR polyA site. A 
neoR probe detected the 4.3-4.5 kb band and a 1.6-1.7 kb band, the expected size 
of RNA transcribed from the SV40 promoter to the 3' LTR polyA (lane 7). The two 
very high molecular weight bands visible in 293--LXSN/gag RNA with both gag 
and neoR probes also hybridized with a pUC19 probe. Since the pUC19 probe is 
homologous with the plasmid backbone of pLXSN outside the L TRs, this indicated 
that the large band is the transfected LXSN/gag plasmid DNA. It appeared to have 
a very high molecular weight because DNA migrates more slowly than RNA of the 
same size on denaturing agarose gels. Detectable levels of gag and neoR 
12345678 12345678 12345678 
9.5-
7.5-
4.4- <:] 
-
2.4-
-
1.4-
0.24-
Gag Probe Neo Probe pUC19 Probe 
Figure 15. Northern blot of RNA from cells containing transfer vectors. Total RNA was electrophoresed through a 
formaldehyde/agarose gel and blotted to a membrane. Lanes 1 and 8 contain 0.24 - 9.5 kb RNA ladders. 
Lane 2 contains RNA from BIV-infected cells. Lane 3 contains PG13 RNA, lane 4 has PG13/LNc8 RNA, 
and lanes 5 and 6 have PG 13--LNCX/CA RNA. Lane 7 has RNA from transiently transfected 293--
LXSN/gag cells. All lanes contain 4 µg of total RNA, except lane 6 which has 7 µg. The open arrowhead 
indicates the 4.3-4.5 kb band in lane 7, and the closed arrowhead indicates the 1.6-1.7 kb band in lane 7. 
The membrane was hybridized with 32P-radiolabeled BIV gag DNA, neoR DNA, and pUC19 DNA. The 
hybridized DNA was stripped from the membrane between different probes. The very strong gag-
hybridizing band in lane 2 was not completely stripped before probing with neoR DNA, but was stripped 
off before probing with pUC19. 
......., 
......., 
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transcription did take place in the 293--LXSN/gag cells (open and closed 
arrowheads), but the RNA bands are very faint, indicating that the level of 
transcription was quite low. A low level of transcription in the 293 cells indicates 
that some protein may have been produced, but it probably was not in sufficient 
amount to detect by ICC or Western blotting 
No signal was detected in any of the lanes with PG 13 RNA, PG 13/LNcS RNA, 
or PG13--LNCX/CA RNA with either a gag or neoR probe. If the expected 
transcription was taking place, the neoR probe should have detected RNA in the 
PG 13/LNcS lane and PG 13--LNCX/CA lanes, and the gag probe should have 
detected RNA bands in the PG13--LNCX/CA lanes. The PG13/LNc8 and PG13--
LNCX/CA cells did possess neomycin-resistance, and so they must have produced 
the neoR protein and neoR RNA. Apparently, if RNA was being produced, the level 
was too low to detect by Northern blot hybridization. 
Dot blotting. A method which is more sensitive at detecting RNA than 
Northern blot hybridization is dot blot hybridization. Because all the RNA in a 
sample is concentrated in one spot on the membrane, different sizes of RNA cannot 
be distinguished, but smaller quantities can be detected. PG13, PG13/LNc8, and 
PG 13--LNCX/CA were analyzed by dot blot hybridization at ten-fold serial dilutions 
(Figure 16). Serial dilutions of pLNCX/CA plasmid DNA were used as a positive 
control. Duplicate blots were made and probed with either BIV gag (Figure 16A) or 
neoR DNA (Figure 168). The gag probe detected the plasmid DNA, but did not 
detect PG 13--LNCX/CA RNA. On the other hand, the neoR probe detected the 
plasmid DNA, as well as PG 13/LNcS RNA and PG 13--LNCX/CA RNA, though the 
signal in PG 13--LNCX/CA cells was much weaker. This indicated that neoR 
transcription off the LNCX/CA transfer vector was taking place at a somewhat low 
level in PG 13--LNCX/CA cells, but transcription of the CA RNA had been reduced 
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Figure 16. Dot blot of total RNA from packaging cells. A duplicate blot of packaging 
cell RNA and pLNCX/CA plasmid DNA was made. The blot shown in 
panel A was hybridized with 32P-labeled BIV gag DNA, and the blot in 
panel B was hybridized with 32P-labeled neoR DNA. 
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to a very low level detectable only by RT-PCR. This result was somewhat 
surprising since the neoR gene should have been transcribed in RNA species 
which contained the CA gene, but by recombination or some other method, this 
aspect of the LNCX/CA transfer vector had been eliminated. The very low level of 
CA transcription in the PG 13--LNCX/CA cells detectable only by RT-PCR 
accounted for the absence of detectable CA protein. 
Low levels of protein 
In order get a better understanding of the levels of protein production that can 
be expected using retroviral gene delivery and in order to verify that the technique 
could be used to express genes in the bovine cells other than resistance markers, 
an LNCX transfer vector carrying green fluorescent protein (GFP) was introduced 
into PG13 packaging cells and into PBAC 798 cells. 
LNCX/GFP. The GPE86--LNCX/GFP packaging cell line was kindly provided 
by John Levy at the Human Gene Therapy Research Institute (Des Moines, Iowa). 
This cell line both produces high levels of GFP protein and of recombinant 
LNCX/GFP retroviral vectors. The GPE86 retrovirus was used to infect PG13 cells, 
which were selected for neomycin resistance at serial dilutions. After three weeks, 
colonies were examined by fluorescent microscopy for fluorescence. Control PG13 
cells had no visible fluorescence. The number of fluorescent and non-fluorescent 
neoR PG13 colonies was counted. Approximately 3% of colonies showed any 
fluorescence, and only 1% fluoresced brightly. In some fluorescent colonies, a 
portion of the cells did not fluoresce. This suggested that as the cells underwent 
division, occasionally expression of the GFP protein was eliminated without loss of 
neomycin resistance, as was observed in the PG13--LNCX/CA cells. In a pool of 
neoR cells, fewer than 1 % of cells fluoresced after three weeks. Since fewer 
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fluorescent cells were visible when cells were grown in the more competitive 
conditions of a cell pool than in the non-competitive conditions of isolated colonies, 
the cells which did not express the GFP protein were presumably able to outgrow 
the GFP-expressing cells. 
Supernatant from the PG13--LNCX/GFP cells was used to infect P8AC 798 
cells, which were then selected for neomycin resistance with G418. Fluorescence 
was visible in more than ten percent of neoR P8AC after three weeks and in one 
hundred percent of cells after six weeks. At three weeks, colonies with fluorescent 
cells did not contain non-fluorescing cells (data not shown). These results 
indicated that P8AC had a higher and more prolonged level of expression of 
transfer vector genes than did packaging cells. 
Gene delivery of LNCX/CA to PBAC 798 cells. If LNCX/CA that was 
delivered to P8AC 798 was expressed in a manner similar to LNCX/GFP, very low 
levels of protein would be present in some clonal colonies. Supernatant was again 
collected from a pool of PG 13--LNCX/CA cells, and the supernatant was used to 
infect P8AC 798. The P8AC were selected for neomycin resistance for three 
weeks, and then stained by ICC using methanol fixation and a Gag-specific Rabbit 
polyclonal antibody. P8AC 798 infected with LNCX/GFP were used as a negative 
control, and their background level of staining was much lower than in normal 
PG 13 cells or F8L cells. Compared with the very low background staining, some of 
the neoR P8AC 798--LNCX/CA colonies showed a very slight positive reaction 
which was higher than anything seen in the negative control cells (data not shown). 
Therefore, a low level of CA protein was produced in infected P8AC 798 cells, and 
this result indicated that protein expression probably had taken place in some of 
the other cells with transfer vectors, but a combination of a low number of 
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expressing cells and a low level of protein production had prevented detection of 
the BIV protein. 
Summary 
Several transfer vectors carrying BIV gag or env8 genes were constructed and 
used to transfect packaging cells. Retroviral vectors from a transfected packaging 
cell line were able to deliver BIV DNA to bovine cells, as detected by the presence 
of neoR colonies. However, no BIV protein was detected in packaging cells, in the 
majority of infected bovine cells, or in transfected 293 cells. In packaging cells with 
the LNCX/CA transfer vector, the neomycin resistance gene (neoR) was 
transcribed, but transcription of the BIV gag gene took place only at an extremely 
low level, as detected by dot blot hybridization and RT-PCR. Both neoR and BIV 
gag RNA was detected by Northern blot in 293 cells transfected with the LXSN/gag 
transfer vector. 
An LNCX transfer vector containing the green fluorescent protein (GFP) was 
successfully expressed in PG13 packaging cells, and recombinant LNCX/GFP 
retroviral vector was used to deliver and successfully express low levels of GFP in 
PBAC 79B cells. Bearing in mind the results with the GFP gene delivery, 
recombinant LNCX/CA retroviral vector was used to infect PBAC 79B cells, and a 
very low level of BIV CA protein was detected in some of the PBAC cells. 
In high endothelial cells, detectable BIV CA protein and GFP protein were 
found. In 293 human kidney cells, transcription driven by both transfer vector 
promoters was detectable by Northern blot, but BIV protein was not detectable. In 
PG13 and FBL cells, both fibroblast cell types, BIV RNA was detected only by RT-
PCR. GFP was weakly detectable in only a fraction of PG13 vector producer cells. 
These results indicated that high endothelial cells were suitable for expression of 
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genes delivered by retroviral vectors, and suggested that cultures of fibroblasts 
may be unsuitable for retroviral gene delivery because of a transcription level too 
low for detectable amounts of protein to be produced. 
These results indicated that retroviral gene delivery may be a suitable method 
to deliver viral genes to bovine target cells for detection of virus specific CTL. 
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DISCUSSION 
Cytotoxic T lymphocytes (CTL) are an important part of the immune system and 
are critical in the control of some intracellular pathogens, including viruses. The 
ability to detect cytotoxic T lymphocytes (CTL) which lyse virus-infected cells is an 
important tool in disease research, from the perspective of natural immunity and in 
vaccine development. Although a variety of different target cells and a number of 
gene delivery methods have been used for CTL research in mice and humans, 
technical difficulties have made detection of virus-specific CTL in cattle impossible 
for many pathogens. 
One obstacle to development of a bovine CTL assay is the lack of a suitable 
target cell. Bovine target cells and CTL must be genetically matched at class I 
MHC loci, and since cattle are outbred, genetically matched target cells and CTL 
can be obtained only by isolating both groups of cells from the same animal. 
Because target cell cultures must be established before CTL can be taken from an 
animal, isolation of the target cells cannot kill the animal. Also, target cells must 
express a relatively high level of class I MHC to ensure that endogenous antigens 
are efficiently presented to T cells. 
The virus can also pose problems in measuring CTL activity. Many viruses are 
only able to infect a limited range of host cells in vitro, and some viruses do not 
grow in vitro at all. Also, many of the viruses which can infect cultured cells lyse the 
cells they infect, creating a background of lysis above which CTL lysis of target 
cells cannot be detected. 
One way that the problems of limited host cell range and viral lysis have been 
overcome in other animals is by using vectored gene delivery to introduce 
individual viral genes into target cells. This method is doubly beneficial in a CTL 
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assay because it allows mapping of CTL responses within the viral genome. 
Retroviral vectors are a promising gene delivery method for use in CTL assays 
because they can deliver genes to cells at high efficiency, the genes are stably 
expressed, and no viral lysis occurs. By using vectored delivery of viral genes, 
limited viral host range is a much smaller consideration, and the choice of target 
cells can be based more on a non-intrusive isolation method and a high level of 
class I MHC expression. 
In the present study, a variety of primary cell cultures were evaluated for their 
potential as target cells in a CTL assay, and the usefulness of retroviral gene 
delivery as a vehicle for introducing viral genes into target cells was assessed. 
Among the different cell cultures examined, a peripheral blood adherent cell 
(PBAC) culture showed the most promise as a potential target cell. Retroviral 
vectors could deliver viral and non-viral genes to PBAC, and low levels of each 
gene's protein product were detected. 
Nine primary cell cultures were examined for their relative levels of class I MHC 
expression and their susceptibility to retroviral gene delivery. These are both 
important characteristics for a target cell in a CTL assay using retroviral gene 
delivery. The cell culture with the best combination of these two characteristics was 
the PBAC 798 culture. PBAC are attractive as target cells because blood cell 
isolations cause little trauma to cattle and are easily performed. The three PBAC 
cultures we examined had different levels of class I MHC expression and 
susceptibility to gene delivery and were further characterized by cell marker 
analyses and functional assays to better determine their cell type and to 
differentiate between them. None of the cultures displayed leukocyte, epithelial, or 
vascular endothelial markers. PBAC 798 cultures were found to be high 
endothelial cells based on a cobblestone morphology typical of endothelial cells 
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and a level of in vitro lymphocyte binding and Dil-Ac-LDL uptake similar to that 
reported for high endothelial cells (45,71 ). P8AC 79A had a low susceptibility to 
gene delivery and P8AC 342 had a low class I MHC expression, making these 
other P8AC cultures much less suitable as target cells than P8AC 798. The PBAC 
79A cells grew much more slowly than 798 cells, had a lower susceptibility to 
retroviral gene delivery, and took up a very low level of Dil-Ac-LDL. Although 
PBAC 342 initially grew in a cobblestone pattern, after two passages the cells grew 
in a more bipolar fibroblastic morphology. The PBAC 342 had a low in vitro 
lymphocyte binding level. 
P8AC 79A and P8AC 798 were isolated from the same blood sample, but 
exhibited different characteristics. The growth rate of the P8AC 79A cells dropped 
as they were cultured, and the low growth rate explained their lower susceptibility 
to gene delivery, since retroviruses only infect dividing cells. Uptake of Dil-Ac-LDL 
has also been found to sometimes drop as cells are cultured in vitro. The P8AC 
79A cells' high lymphocyte binding and occasional cobblestone morphology 
indicate that they probably contain high endothelial cells and were originally 
identical to PBAC 798. The 79A cells experienced a drop in growth rate and Dil-Ac-
LDL uptake during culture, and consequently lost their suitability as potential target 
cells. The PBAC 342 culture, on the other hand, had a class I MHC expression and 
susceptibility to retroviral gene delivery in the range of the fibroblastic primary cell 
isolates. Also, they did not bind lymphocytes in vitro, and they grew in bipolar 
arrays. These characteristics all indicate that the PBAC 342 culture was composed 
primarily of fibroblasts, not high endothelial cells. Their initial morphology was 
characteristic of high endothelial cells, but the culture probably was overgrown by 
fibroblasts after several passages. All the fibroblasts that we tested were not 
suitable as potential CTL target cells. 
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In order for PBAC cultures to be routinely used as CTL target cells, it would be 
necessary to distinguish good potential target cells from bad ones. A doubling time 
of at most five days is necessary for good susceptibility to gene delivery. A level of 
lymphocyte binding higher than 0.4 lymphocytes per cell would indicate that the 
cultures are high endothelial cells, and not fibroblasts. PBAC cultures with a short 
doubling time and high lymphocyte binding correlate with a high potential as CTL 
target cells. 
Retroviral vectors were used to deliver bovine immunodeficiency virus (BIV) 
genes to bovine cells to test the usefulness of this gene delivery method in a 
bovine CTL assay. Several retroviral transfer vectors were constructed with 
different portions of the BIV gag gene or the BIV env gene and using either the 
LNCX or LXSN transfer vector backbone. The BIV transfer vectors were 
transfected into packaging cells and into 293 human kidney cells, and in all 
experiments no BIV protein was detectable. In transiently transfected cells, the BIV 
genes were transcribed at a low level, and a small but undetectable level of 
translation may have also taken place. In stably transfected packaging cells, the 
transfer vector's antibiotic resistance gene was readily transcribed, but the BIV 
gene was transcribed at an extremely low level. In the packaging cells, very little 
BIV protein, if any, could have been produced. When recombinant retroviral 
vectors from packaging cells were used to deliver BIV genes to PBAC 798 cells, a 
barely detectable amount of BIV protein was produced in some antibiotic-resistant 
colonies. Thus, bovine viral genes could be delivered and expressed, albeit at a 
low level, to potential bovine CTL target cells. 
A recombinant retroviral vector containing green fluorescent protein (GFP) was 
also used to infect bovine cells. Detection of GFP is much more sensitive than 
detection of the BIV genes. PBAC took up the GFP gene and showed green 
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fluorescence. The level of fluorescence was low, but it was more easily visible than 
the reaction with BIV protein had been. The expression of GFP in the PBAC 
confirmed the ability of retroviral gene delivery to introduce genes into potential 
bovine CTL target cells, and it confirmed that those genes were expressed. 
A low level of expression of retroviral vector-delivered genes was observed, 
though the level varied between clonally derived populations of cells. When a 
retroviral vector infects a cell, the genes it carries are integrated at a random site in 
the host cell DNA. If the vector integrates into a chromosome region that is 
transcriptionally silent, the retroviral genes will likely also be silenced. Even if the 
retroviral vector integrates into a transcriptionally active region, the L TR or CMV 
promoters of the vector can become hypermethylated after integration causing a 
change in chromatin conformation which can also down-regulate transcription of 
the inserted genes (38). The problem of down-regulation of the retrovirus-
delivered genes can be avoided by testing the expression levels of a large number 
of clonally derived populations of infected cells and selecting the highest 
expressors (56). Other researchers have used retroviral gene delivery of HIV and 
FIV genes to CTL target cells to measure the specificity of CTL lysis to viral genes 
in naturally infected animals (69,78). In the measurement of FIV-specific CTL, a 
low level of FIV CA gene expression was also found, but protein levels were 
sufficient to stimulate CTL to lyse cells. In the research using retroviral vectors 
carrying HIV net, a number of different cell clones were screened and one with high 
expression levels was used. The field of retroviral gene delivery continues to 
develop, and as it does retroviral vectors which elicit higher and more consistent 
levels of expression will become available. 
The genes delivered to bovine cells in this study using retroviral gene delivery 
were transcribed and translated at a low level, but a low level of expression may be 
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sufficient for use in a CTL assay. Unlike the humoral immune system, CTL can 
react to cells which present only 100 molecules of antigen on their surface (21,82), 
thus a low level of expression can be sufficient to elicit lysis of infected target cells. 
The most sensitive test of protein expression is CTL lysis of target cells, and that 
test has not yet been performed. 
In summary, adherent high endothelial cells cultured from peripheral blood 
were found to have a high potential as target cells for a CTL assay. These cells 
could prove widely useful in measuring bovine CTL activity to viruses. Retroviral 
gene delivery was successfully used to deliver and express viral and non-viral 
genes to high endothelial cells. The use of retroviral vectors for construction of a 
bovine CTL assay system which is proposed in this research has a real potential to 
allow elucidation of bovine cellular immune responses to viruses which until now 
have been impossible to measure. The next step in this line of research is to use 
the CTL assay outlined here to try to detect cellular immune responses in virus-
infected cattle. 
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APPENDIX A. SOLUTION RECIPES 
Agarose/formaldehyde gel 1.2% agarose, 1 X MESA buffert, 6.7% (2.2 M) 
formaldehyde, and 0.1 µg/ml ethidium bromide 
Alkaline Transfer Buffer 1.5 M NaCl, 0.25 M NaOH 
Ambion's Gel Loading Buffer II 95% formamide, 0.025% xylene cyanol, 0.025% 
bromophenol blue, 0.5 mM EDTA, 0.025% SOS 
Denhardt's reagent 
DMEM 
FAGS buffer 
2X HBS 
HBSS 
IH Buffer 1 
1X MESA Buffer 
NZY broth 
PBS 
Qiagen Wash Buffer 
Qiagen Elution Buffer 
RBC Lysis buffer 
Restoring buffer 
10 g/I Ficoll, 10 g/I polyvinylpyrrolidone, and 1 O g/I 
BSA 
distilled water treated for at least 16 hours with 0.1-
0.2% DEPC to inactivate RNases and 
autoclaved to remove the DEPC 
Dulbecco's modified Eagle's medium (Sigma), 4.5 
mg/ml glucose, 1.2 mg/ml L-glutamine, 3.7 
mg/ml sodium bicarbonate, 100 U/ml Penicillin, 
100 µg/ml streptomycin, final pH 7.4 
PBS with 0.1 % sodium azide and 1 % BSA 
280 mMNaCI, 10 mMKCI, 1.5 mMNa2HP04 , 12 
mM dextrose, 50 mM Hepes, final pH 7.05 
Hanks' balanced salt solution (Sigma), 0.35 mg/ml 
sodium bicarbonate, final pH 7.4 
50 mMglucose, 10 mMEDTA, 25 mMTris•HCI pH 
8.0 
40 mM MOPS pH 7.0, 1 O mM sodium acetate, 1 
mMEDTA 
16 g/I NZ broth powder (Gibco), 5 g/I yeast extract, 
final pH 7.2 
120 mM NaCl, 2.7 mM KCI, 10 mM sodium 
phosphate buffer, final pH 7.4 
1.0 M NaCl, 50 mM MOPS pH 7.0, 15% ethanol 
1.25 M Nacl, 50 mM Tris-HCI pH 8.5, 15% ethanol 
6 mM Na2HP04 , 4-6 mM KH2P04 , final pH 7.4 
460 mM NaCl, 6 mM Na2HP04 , 1.5-2.5 mM 
KH2P04 , final pH 7.4 
SOB 
soc 
Sodium phosphate buffer 
Southern I Buffer 
1X SSC 
1X SSPE 
STV ( saline-trypsin-versene) 
Super Broth 
1XTE 
TAE buffer 
TFB (transformation buffer) 
TN 
TNFBS 
TBS 
TTBS 
5X Western running buffer 
2X Western sample buffer 
Western transfer buffer 
YT-carbenicillin plates 
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20 g/1 of bacto-tryptone, 5 g/I of yeast extract, 1 O 
mMNaCI, 2.5 mMKCI, 10 mMMgS04 , 10 mM 
MgCl2 , final pH 7.5 
SOB with 20 mM glucose 
mixture of equimolar solutions of NaH2P04 and 
Na2HP04 , to a desired pH 
1.5 M NaCl, 0.5 M NaOH 
150 mM NaCl, 15 mM sodium citrate, final pH 7.0 
180 mMNaCI, 10 mMNaH2P04 , 1 mMEOTA, final 
pH 7.4 
8 g/I NaCl, 0.4 g/I KCI, 1 g/I glucose, 0.58 g/I 
sodium bicarbonate, 0.5 g/I trypsin, 0.2 g/I 
EOTA, 4.5x10-4% phenol red) 
12 g/I peptone 140, 24 g/I yeast extract, 0.4% 
glycerol, 17 mMKH2P04 , 72 mMK2HP04 
10 mMTris pH 8.0, 1 mMEOTA 
40 mMTris, 83 mMsodium acetate, 1 mMEOTA, 
final pH 7.9 
10 mM MES pH 6.3, 45 mM MnCl2•4H20, 10 mM 
CaCl2•2H20, 10 mM RuCI, 3 mM hexamine 
cobalt (Ill) chloride 
10 mMTris, 150 mM NaCl, final pH 7.4 
TNt with 1 % FBS 
0.2 M NaCl, 50 mM Tris 
TBSt with 0.1 % Tween-20 (Sigma) 
15 g/I Tris, 72 g/I glycine, 5 g/I SOS, final pH 8.3 
4% SOS, 20 mM sodium phosphate buffert, pH 
7.0, 20% glycerol, 10% B-mercaptoethanol, 0.2 
M dithiothreitol, 0.02% bromophenol blue 
20% methanol, 25 mM Tris, 192 mM glycine, final 
pH 8.3 
1.5 % agar, 8 g/I bacto-tryptone, 5 g/I bacto-yeast 
extract, 5 g/I NaCl, 250 µg/ml carbenicillin 
ACD 
APS 
BSA 
DEPC 
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APPENDIX B. ABBREVIATIONS 
acid, citrate, dextrose 
ammonium persulfate 
bovine serum albumin (Fraction V, Sigma) 
diethylpyrocarbonate 
Dil-Ac-LDL 1, 1 '-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate 
(Dil)-labelled acetylated low density lipoprotein 
DMF 
EDTA 
FACS 
FBS 
FITC 
HBSS 
IPTG 
MES 
MESA 
MOPS 
PBAC 
PBMC 
PBS 
PCR 
PEGaooo 
PVDF 
RBC 
RT-PCR 
sos 
SSC 
SSPE 
STV 
TE MED 
TFB 
N, N-dimethylformamide 
ethylenediaminetetraacetic acid 
fluorescent antibody cell sorting 
fetal bovine serum 
fluoroscein isothiocyanate 
Hank's buffered salt solution (se Solution Recipes) 
isopropyl B-D-thiogalactopyranoside 
2-(N-morpholino)ethanesulfonic acid 
MOPS, EDTA, sodium acetate (see Solution Recipes) 
3-(N-morpholino )propanesulfonic acid 
peripheral blood adherent eels 
peripheral blood mononuclear cells 
phosphate buffered saline (see Solution Recipes) 
polymerase chain reaction 
polyethylene glycol, 8000 average molecular weight 
polyvinylidene difluoride 
red blood cell 
reverse transcription - PCR 
sodium dodecyl sulfate 
standard sodium citrate (see Solution Recipes) 
standard sodium phosphate-EDTA (see Solution Recipes) 
saline-trypsin-versene (see Solution Recipes) 
N,N,N',N'-tetramethylethylenediamine 
transformation buffer (see Solution Recipes) 
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TN Tris-NaCl (see Solution Recipes) 
TTBS Tween-20, Tris-buffered saline (see Solution Recipes) 
X-Gal 5-bromo-4-chloro-3-indolyl-B-D-galactoside in DMF 
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